10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

Or

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number 1-11239

HCA Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware	27-3865930
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
One Park Plaza Nashville, Tennessee	37203
(Address of principal executive offices)	(Zip Code)

(615) 344-9551

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	x	Accelerated filer	¨
Non-accelerated filer	¨ (Do not check if a smaller reporting company)	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.

Class of Common Stock	Outstanding at October 31, 2013
Voting common stock, $.01 par value	447,838,000 shares

HCA HOLDINGS, INC.

Form 10-Q

September 30, 2013

		Page of Form 10-Q
Part I.	Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Income Statements — for the quarters and nine months ended September  30, 2013 and 2012		2
	Condensed Consolidated Comprehensive Income Statements — for the quarters and nine months ended September 30, 2013 and 2012		3
	Condensed Consolidated Balance Sheets — September 30, 2013 and December 31, 2012		4
	Condensed Consolidated Statements of Cash Flows  — for the nine months ended September 30, 2013 and 2012		5
	Notes to Condensed Consolidated Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		30
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		49
Item 4.	Controls and Procedures		49
Part II.	Other Information
Item 1.	Legal Proceedings		49
Item 1A.	Risk Factors		51
Item 6.	Exhibits		51
Signatures			52

1

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED INCOME STATEMENTS

FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2013 AND 2012

Unaudited

(Dollars in millions, except per share amounts)

	Quarter						Nine Months
	2013			2012			2013			2012
Revenues before provision for doubtful accounts	$	9,411		$	8,893		$	28,078		$	27,245
Provision for doubtful accounts		955			831			2,732			2,666
Revenues		8,456			8,062			25,346			24,579
Salaries and benefits		3,916			3,781			11,681			11,224
Supplies		1,457			1,375			4,406			4,216
Other operating expenses		1,564			1,510			4,594			4,496
Electronic health record incentive income		(75	)		(131	)		(166	)		(256	)
Equity in earnings of affiliates		(9	)		(6	)		(29	)		(26	)
Depreciation and amortization		443			417			1,292			1,254
Interest expense		458			446			1,392			1,336
Losses (gains) on sales of facilities		1			(7	)		13			(4	)
Loss on retirement of debt		—			—			17			—
		7,755			7,385			23,200			22,240
Income before income taxes		701			677			2,146			2,339
Provision for income taxes		234			222			704			760
Net income		467			455			1,442			1,579
Net income attributable to noncontrolling interests		102			95			310			288
Net income attributable to HCA Holdings, Inc.	$	365		$	360		$	1,132		$	1,291
Per share data:
Basic earnings per share	$	0.82		$	0.82		$	2.54		$	2.94
Diluted earnings per share	$	0.79		$	0.78		$	2.44		$	2.81
Cash dividends declared per share	$	—		$	—		$	—		$	2.00
Shares used in earnings per share calculations (in thousands):
Basic		447,329			440,899			446,125			439,441
Diluted		463,569			459,515			463,051			458,822

See accompanying notes.

2

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS

FOR THE QUARTERS AND NINE MONTHS ENDED SEPTEMBER 30, 2013 AND 2012

Unaudited

(Dollars in millions)

	Quarter						Nine Months
	2013			2012			2013			2012
Net income	$	467		$	455		$	1,442		$	1,579
Other comprehensive income (loss) before taxes:
Foreign currency translation		60			30			—			37
Unrealized (losses) gains on available-for-sale securities		1			3			(7	)		8
Defined benefit plans		8			—			8			—
Pension costs included in salaries and benefits		9			7			24			21
		17			7			32			21
Change in fair value of derivative financial instruments		(31	)		(56	)		9			(158	)
Interest costs included in interest expense		33			30			97			90
		2			(26	)		106			(68	)
Other comprehensive income (loss) before taxes		80			14			131			(2	)
Income taxes (benefits) related to other comprehensive income items		28			5			48			(2	)
Other comprehensive income		52			9			83			—
Comprehensive income		519			464			1,525			1,579
Comprehensive income attributable to noncontrolling interests		102			95			310			288
Comprehensive income attributable to HCA Holdings, Inc.	$	417		$	369		$	1,215		$	1,291

See accompanying notes.

3

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

Unaudited

(Dollars in millions)

	September 30, 2013			December 31, 2012
ASSETS
Current assets:
Cash and cash equivalents	$	484		$	705
Accounts receivable, less allowance for doubtful accounts of $5,105 and $4,846		4,924			4,672
Inventories		1,135			1,086
Deferred income taxes		400			385
Other		828			915
		7,771			7,763
Property and equipment, at cost		30,472			29,527
Accumulated depreciation		(17,150	)		(16,342	)
		13,322			13,185
Investments of insurance subsidiaries		402			515
Investments in and advances to affiliates		125			104
Goodwill and other intangible assets		5,832			5,539
Deferred loan costs		250			290
Other		691			679
	$	28,393		$	28,075
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable	$	1,582		$	1,768
Accrued salaries		1,085			1,120
Other accrued expenses		1,764			1,849
Long-term debt due within one year		988			1,435
		5,419			6,172
Long-term debt		27,389			27,495
Professional liability risks		959			973
Income taxes and other liabilities		1,670			1,776
Stockholders’ deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 447,573,400 shares in 2013 and 443,200,200 shares in 2012		4			4
Capital in excess of par value		1,821			1,753
Accumulated other comprehensive loss		(374	)		(457	)
Retained deficit		(9,827	)		(10,960	)
Stockholders’ deficit attributable to HCA Holdings, Inc.		(8,376	)		(9,660	)
Noncontrolling interests		1,332			1,319
		(7,044	)		(8,341	)
	$	28,393		$	28,075

See accompanying notes.

4

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013 AND 2012

Unaudited

(Dollars in millions)

	2013			2012
Cash flows from operating activities:
Net income	$	1,442		$	1,579
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities		(3,319	)		(2,923	)
Provision for doubtful accounts		2,732			2,666
Depreciation and amortization		1,292			1,254
Income taxes		158			250
Losses (gains) on sales of facilities		13			(4	)
Loss on retirement of debt		17			—
Amortization of deferred loan costs		41			44
Share-based compensation		81			39
Other		(3	)		7
Net cash provided by operating activities		2,454			2,912
Cash flows from investing activities:
Purchase of property and equipment		(1,347	)		(1,268	)
Acquisition of hospitals and health care entities		(463	)		(167	)
Disposition of hospitals and health care entities		31			17
Change in investments		97			73
Other		8			5
Net cash used in investing activities		(1,674	)		(1,340	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350
Net change in revolving credit facilities		630			(875	)
Repayment of long-term debt		(1,300	)		(689	)
Distributions to noncontrolling interests		(308	)		(303	)
Payment of debt issuance costs		(5	)		(20	)
Distributions to stockholders		(13	)		(983	)
Income tax benefits		70			82
Other		(75	)		(35	)
Net cash used in financing activities		(1,001	)		(1,473	)
Change in cash and cash equivalents		(221	)		99
Cash and cash equivalents at beginning of period		705			373
Cash and cash equivalents at end of period	$	484		$	472
Interest payments	$	1,464		$	1,404
Income tax payments, net	$	476		$	428

See accompanying notes.

5

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At September 30, 2013, these affiliates owned and operated 162 hospitals, 114 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $76 million and $62 million for the quarters ended September 30, 2013 and 2012, respectively, and $207 million and $174 million for the nine months ended September 30, 2013 and 2012, respectively. Operating results for the quarter and the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

6

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation (continued)

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,847			21.8	%	$	1,949			24.2	%
Managed Medicare		794			9.4			720			8.9
Medicaid		401			4.7			378			4.7
Managed Medicaid		386			4.6			380			4.7
Managed care and other insurers		4,636			54.8			4,422			54.8
International (managed care and other insurers)		287			3.4			253			3.1
		8,351			98.7			8,102			100.4
Uninsured		717			8.5			576			7.1
Other		343			4.1			215			2.7
Revenues before provision for doubtful accounts		9,411			111.3			8,893			110.2
Provision for doubtful accounts		(955	)		(11.3	)		(831	)		(10.2	)
Revenues	$	8,456			100.0	%	$	8,062			100.0	%

	Nine Months
	2013			Ratio			2012			Ratio
Medicare	$	5,961			23.5	%	$	6,251			25.4	%
Managed Medicare		2,441			9.6			2,199			8.9
Medicaid		1,098			4.3			1,188			4.8
Managed Medicaid		1,165			4.6			1,080			4.4
Managed care and other insurers		13,777			54.4			13,340			54.3
International (managed care and other insurers)		868			3.4			779			3.2
		25,310			99.8			24,837			101.0
Uninsured		1,809			7.1			1,757			7.1
Other		959			3.8			651			2.7
Revenues before provision for doubtful accounts		28,078			110.7			27,245			110.8
Provision for doubtful accounts		(2,732	)		(10.7	)		(2,666	)		(10.8	)
Revenues	$	25,346			100.0	%	$	24,579			100.0	%

Medicare revenues for the nine months ended September 30, 2012 were impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271

7

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued)

Basis of Presentation (continued)

million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the nine months ended September 30, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the nine months ended September 30, 2013, we paid $278 million and recorded goodwill and identifiable intangible assets of $180 million and $113 million, respectively, related to the acquisition of The Outsource Group, which was acquired by our Parallon Business Solutions affiliate and is included in the Corporate and other Group. During the nine months ended September 30, 2013, we also paid $39 million to acquire nonhospital health care entities and $146 million related to the acquisition of three hospitals which became effective October 1, 2013. During the nine months ended September 30, 2012, we paid $58 million, assumed liabilities of $33 million and recorded goodwill of $53 million related to the acquisition of a hospital facility in the American Group, and we paid $109 million to acquire nonhospital health care entities.

During the nine months ended September 30, 2013, we received proceeds of $31 million and recognized a net pretax loss of $13 million related to the sale of a hospital facility and other real estate investments. During the nine months ended September 30, 2012, we received proceeds of $17 million and recognized a net pretax gain of $4 million related to sales of real estate investments.

NOTE 3 — INCOME TAXES

During the nine months ended September 30, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2011 federal income tax return in 2014.

Our liability for unrecognized tax benefits was $417 million, including accrued interest of $26 million, as of September 30, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $151 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $7 million and $1 million ($4 million and none, respectively, net of tax) of interest expense related to taxing authority examinations for the quarters ended September 30, 2013 and 2012, respectively, and $8 million and $20 million ($5 million and $13 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the nine months ended September 30, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

8

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters and nine months ended September 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Nine Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	365	$	360	$	1,132	$	1,291
Weighted average common shares outstanding		447,329		440,899		446,125		439,441
Effect of dilutive incremental shares		16,240		18,616		16,926		19,381
Shares used for diluted earnings per share		463,569		459,515		463,051		458,822
Earnings per share:
Basic earnings per share	$	0.82	$	0.82	$	2.54	$	2.94
Diluted earnings per share	$	0.79	$	0.78	$	2.44	$	2.81

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at September 30, 2013 and December 31, 2012 follows (dollars in millions):

	September 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	383	$	12	$	(2	)	$	393
Auction rate securities		32		—		—			32
Asset-backed securities		13		—		—			13
Money market funds		24		—		—			24
		452		12		(2	)		462
Equity securities		2		1		—			3
	$	454	$	13	$	(2	)		465
Amounts classified as current assets									(63	)
Investment carrying value								$	402

9

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES (continued)

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

At September 30, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At September 30, 2013 and December 31, 2012, $1 million and $9 million, respectively, of our money market fund investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at September 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	41	$	41
Due after one year through five years		176		182
Due after five years through ten years		108		111
Due after ten years		82		83
		407		417
Auction rate securities		32		32
Asset-backed securities		13		13
	$	452	$	462

The average expected maturity of the investments in debt securities at September 30, 2013 was 4.0 years, compared to the average scheduled maturity of 7.1 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At September 30, 2013, the average expected maturities for our auction rate and asset-backed securities were 1.4 years and 3.9 years, respectively, compared to average scheduled maturities of 22.1 years and 22.7 years, respectively.

10

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at September 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(6	)
Pay-fixed interest rate swaps		3,000		December 2016		(269	)
Pay-fixed interest rate swaps		1,000		December 2017		(48	)

During the next 12 months, we estimate $127 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at September 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(4	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the nine months ended September 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	6		Interest expense	$	97

11

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 6 — FINANCIAL INSTRUMENTS (continued)

Derivatives — Results of Operations (continued)

Derivatives Not Designated as Hedging Instruments	Location of Gain Recognized in Operations on Derivatives		Amount of Gain Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of September 30, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at September 30, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $341 million.

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within

12

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Cash Traded Investments (continued)

Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at September 30, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

13

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Derivative Financial Instruments (continued)

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	September 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	393		$	—		$	393		$	—
Auction rate securities		32			—			—			32
Asset-backed securities		13			—			13			—
Money market funds		24			24			—			—
		462			24			406			32
Equity securities		3			2			—			1
Investments of insurance subsidiaries		465			26			406			33
Less amounts classified as current assets		(63	)		(24	)		(39	)		—
	$	402		$	2		$	367		$	33
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	4		$	—		$	4		$	—
Interest rate swaps (Income taxes and other liabilities)		323			—			323			—

14

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (continued)

Derivative Financial Instruments (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the nine months ended September 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$70
Unrealized gains included in other comprehensive income		6
Settlements		(43	)
Asset balances at September 30, 2013	$	33

The estimated fair value of our long-term debt was $29.492 billion and $30.781 billion at September 30, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.377 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

15

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at September 30, 2013 and December 31, 2012, including related interest rates at September 30, 2013, follows (dollars in millions):

	September 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,100	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,944		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,693		9,688
Other senior secured debt (effective interest rate of 6.8%)		446		423
First lien debt		18,183		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,194		11,194
Total debt (average life of 6.5 years, rates averaging 6.3%)		28,377		28,930
Less amounts due within one year		988		1,435
	$	27,389	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal

16

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Government Investigations, Claims and Litigation (continued)

government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class

17

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS (continued)

Securities Class Action Litigation (continued)

actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action had also been stayed pending developments in the shareholder class actions, but that stay has expired. The plaintiff in the state derivative action subsequently filed an amended complaint on September 9, 2013 that added additional allegations made in the shareholder class actions. The Company has filed a motion to again stay the state derivative action pending developments in the class action, but the Court has not yet acted on that motion. On September 24, 2013, an additional state derivative action, Steinberg v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court. This action against our board of directors is substantially similar to the earlier filed state derivative action and the Company is attempting to consolidate the two state actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

18

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			1,132			310			1,442
Other comprehensive income		—		—		—			83			—			—			83
Distributions		—		—		—			—			—			(308	)		(308	)
Share-based benefit plans		4,373		—		71			—			—			—			71
Other		—		—		(3	)		—			1			11			9
Balances at September 30, 2013		447,573	$	4	$	1,821		$	(374	)	$	(9,827	)	$	1,332		$	(7,044	)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(4	)		—			—			—			(4	)
Defined benefit plans, net of $3 of income taxes		—			—			5			—			5
Change in fair value of derivative instruments, net of $3 of income taxes		—			—			—			6			6
Expense reclassified into operations from other comprehensive income, net of $9 and $36, respectively, income tax benefits		—			—			15			61			76
Balances at September 30, 2013	$	7		$	(1	)	$	(176	)	$	(204	)	$	(374	)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 79 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

19

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION (continued)

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Nine Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,930		$	3,755		$	11,875		$	11,553
American Group		4,082			3,982			12,181			12,033
Corporate and other		444			325			1,290			993
	$	8,456		$	8,062		$	25,346		$	24,579
Equity in earnings of affiliates:
National Group	$	(3	)	$	—		$	(8	)	$	(7	)
American Group		(6	)		(6	)		(19	)		(20	)
Corporate and other		—			—			(2	)		1
	$	(9	)	$	(6	)	$	(29	)	$	(26	)
Adjusted segment EBITDA:
National Group	$	805		$	768		$	2,440		$	2,478
American Group		910			843			2,654			2,657
Corporate and other		(112	)		(78	)		(234	)		(210	)
	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization:
National Group	$	181		$	171		$	532		$	520
American Group		206			207			610			612
Corporate and other		56			39			150			122
	$	443		$	417		$	1,292		$	1,254
Adjusted segment EBITDA	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization		443			417			1,292			1,254
Interest expense		458			446			1,392			1,336
Losses (gains) on sales of facilities		1			(7	)		13			(4	)
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	701		$	677		$	2,146		$	2,339

20

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters and nine months ended September 30, 2013 and 2012, condensed consolidating balance sheets at September 30, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the nine months ended September 30, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,945		$	4,466		$	—		$	9,411
Provision for doubtful accounts		—			—			560			395			—			955
Revenues		—			—			4,385			4,071			—			8,456
Salaries and benefits		—			—			2,090			1,826			—			3,916
Supplies		—			—			773			684			—			1,457
Other operating expenses		2			(1	)		771			792			—			1,564
Electronic health record incentive income		—			—			(53	)		(22	)		—			(75	)
Equity in earnings of affiliates		(443	)		—			—			(9	)		443			(9	)
Depreciation and amortization		—			—			216			227			—			443
Interest expense		41			549			(104	)		(28	)		—			458
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(183	)		183			—			—
		(400	)		548			3,511			3,653			443			7,755
Income (loss) before income taxes		400			(548	)		874			418			(443	)		701
Provision (benefit) for income taxes		(17	)		(214	)		334			131			—			234
Net income (loss)		417			(334	)		540			287			(443	)		467
Net income attributable to noncontrolling interests		—			—			19			83			—			102
Net income (loss) attributable to HCA Holdings, Inc.	$	417		$	(334	)	$	521		$	204		$	(443	)	$	365
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	417		$	(331	)	$	532		$	242		$	(443	)	$	417

21

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,672		$	4,221		$	—		$	8,893
Provision for doubtful accounts		—			—			484			347			—			831
Revenues		—			—			4,188			3,874			—			8,062
Salaries and benefits		—			—			1,995			1,786			—			3,781
Supplies		—			—			711			664			—			1,375
Other operating expenses		—			3			761			746			—			1,510
Electronic health record incentive income		—			—			(85	)		(46	)		—			(131	)
Equity in earnings of affiliates		(379	)		—			(1	)		(5	)		379			(6	)
Depreciation and amortization		—			—			205			212			—			417
Interest expense		30			545			(98	)		(31	)		—			446
Gains on sales of facilities		—			—			—			(7	)		—			(7	)
Management fees		—			—			(170	)		170			—			—
		(349	)		548			3,318			3,489			379			7,385
Income (loss) before income taxes		349			(548	)		870			385			(379	)		677
Provision (benefit) for income taxes		(11	)		(208	)		325			116			—			222
Net income (loss)		360			(340	)		545			269			(379	)		455
Net income attributable to noncontrolling interests		—			—			18			77			—			95
Net income (loss) attributable to HCA Holdings, Inc.	$	360		$	(340	)	$	527		$	192		$	(379	)	$	360
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	360		$	(357	)	$	531		$	214		$	(379	)	$	369

22

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,829		$	13,249		$	—		$	28,078
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Revenues		—			—			13,218			12,128			—			25,346
Salaries and benefits		—			—			6,275			5,406			—			11,681
Supplies		—			—			2,340			2,066			—			4,406
Other operating expenses		4			(1	)		2,260			2,331			—			4,594
Electronic health record incentive income		—			—			(115	)		(51	)		—			(166	)
Equity in earnings of affiliates		(1,303	)		—			(2	)		(27	)		1,303			(29	)
Depreciation and amortization		—			—			636			656			—			1,292
Interest expense		138			1,651			(319	)		(78	)		—			1,392
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(547	)		547			—			—
		(1,161	)		1,667			10,548			10,843			1,303			23,200
Income (loss) before income taxes		1,161			(1,667	)		2,670			1,285			(1,303	)		2,146
Provision (benefit) for income taxes		(54	)		(639	)		1,005			392			—			704
Net income (loss)		1,215			(1,028	)		1,665			893			(1,303	)		1,442
Net income attributable to noncontrolling interests		—			—			48			262			—			310
Net income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(1,028	)	$	1,617		$	631		$	(1,303	)	$	1,132
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(961	)	$	1,637		$	627		$	(1,303	)	$	1,215

23

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,328		$	12,917		$	—		$	27,245
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Revenues		—			—			12,823			11,756			—			24,579
Salaries and benefits		—			—			5,928			5,296			—			11,224
Supplies		—			—			2,202			2,014			—			4,216
Other operating expenses		—			7			2,241			2,248			—			4,496
Electronic health record incentive income		—			—			(174	)		(82	)		—			(256	)
Equity in earnings of affiliates		(1,348	)		—			(4	)		(22	)		1,348			(26	)
Depreciation and amortization		—			—			614			640			—			1,254
Interest expense		90			1,603			(274	)		(83	)		—			1,336
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(498	)		498			—			—
		(1,258	)		1,610			10,038			10,502			1,348			22,240
Income (loss) before income taxes		1,258			(1,610	)		2,785			1,254			(1,348	)		2,339
Provision (benefit) for income taxes		(33	)		(597	)		1,014			376			—			760
Net income (loss)		1,291			(1,013	)		1,771			878			(1,348	)		1,579
Net income attributable to noncontrolling interests		—			—			51			237			—			288
Net income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,013	)	$	1,720		$	641		$	(1,348	)	$	1,291
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,055	)	$	1,733		$	670		$	(1,348	)	$	1,291

24

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	167		$	317	$	—		$	484
Accounts receivable, net		—			—			2,481			2,443		—			4,924
Inventories		—			—			667			468		—			1,135
Deferred income taxes		400			—			—			—		—			400
Other		6			—			327			495		—			828
		406			—			3,642			3,723		—			7,771
Property and equipment, net		—			—			7,467			5,855		—			13,322
Investments of insurance subsidiaries		—			—			—			402		—			402
Investments in and advances to affiliates		19,784			—			15			110		(19,784	)		125
Goodwill and other intangible assets		—			—			1,695			4,137		—			5,832
Deferred loan costs		30			220			—			—		—			250
Other		315			—			37			339		—			691
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,012		$	569	$	—		$	1,582
Accrued salaries		—			—			634			451		—			1,085
Other accrued expenses		255			259			441			809		—			1,764
Long-term debt due within one year		—			906			43			39		—			988
		256			1,165			2,130			1,868		—			5,419
Long-term debt		2,525			24,174			165			525		—			27,389
Intercompany balances		25,682			(10,477	)		(18,677	)		3,472		—			—
Professional liability risks		—			—			—			959		—			959
Income taxes and other liabilities		448			327			639			256		—			1,670
		28,911			15,189			(15,743	)		7,080		—			35,437
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,376	)		(14,969	)		28,484			6,269		(19,784	)		(8,376	)
Noncontrolling interests		—			—			115			1,217		—			1,332
		(8,376	)		(14,969	)		28,599			7,486		(19,784	)		(7,044	)
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393

25

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

26

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,215		$	(1,028	)	$	1,665		$	893		$	(1,303	)	$	1,442
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		47			(126	)		(1,848	)		(1,392	)		—			(3,319	)
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Depreciation and amortization		—			—			636			656			—			1,292
Income taxes		158			—			—			—			—			158
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		3			38			—			—			—			41
Share-based compensation		81			—			—			—			—			81
Equity in earnings of affiliates		(1,303	)		—			—			—			1,303			—
Other		—			7			—			(10	)		—			(3	)
Net cash provided by (used in) operating activities		201			(1,092	)		2,084			1,261			—			2,454
Cash flows from investing activities:
Purchase of property and equipment		—			—			(684	)		(663	)		—			(1,347	)
Acquisition of hospitals and health care entities		—			—			—			(463	)		—			(463	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			(6	)		103			—			97
Other		—			—			—			8			—			8
Net cash used in investing activities		—			—			(673	)		(1,001	)		—			(1,674	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			630			—			—			—			630
Repayment of long-term debt		—			(1,243	)		(34	)		(23	)		—			(1,300	)
Distributions to noncontrolling interests		—			—			(34	)		(274	)		—			(308	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(13	)		—			—			—			—			(13	)
Changes in intercompany balances with affiliates, net		(199	)		1,710			(1,559	)		48			—			—
Income tax benefits		70			—			—			—			—			70
Other		(81	)		—			—			6			—			(75	)
Net cash (used in) provided by financing activities		(223	)		1,092			(1,627	)		(243	)		—			(1,001	)
Change in cash and cash equivalents		(22	)		—			(216	)		17			—			(221	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	167		$	317		$	—		$	484

27

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,291		$	(1,013	)	$	1,771		$	878		$	(1,348	)	$	1,579
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(131	)		(1,475	)		(1,347	)		—			(2,923	)
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Depreciation and amortization		—			—			614			640			—			1,254
Income taxes		250			—			—			—			—			250
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Amortization of deferred loan costs		1			43			—			—			—			44
Share-based compensation		39			—			—			—			—			39
Equity in earnings of affiliates		(1,348	)		—			—			—			1,348			—
Other		—			11			—			(4	)		—			7
Net cash provided by (used in) operating activities		263			(1,090	)		2,418			1,321			—			2,912
Cash flows from investing activities:
Purchase of property and equipment		—			—			(685	)		(583	)		—			(1,268	)
Acquisition of hospitals and health care entities		—			—			(72	)		(95	)		—			(167	)
Disposition of hospitals and health care entities		—			—			1			16			—			17
Change in investments		—			—			(9	)		82			—			73
Other		—			—			(1	)		6			—			5
Net cash used in investing activities		—			—			(766	)		(574	)		—			(1,340	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(875	)		—			—			—			(875	)
Repayment of long-term debt		—			(604	)		(16	)		(69	)		—			(689	)
Distributions to noncontrolling interests		—			—			(46	)		(257	)		—			(303	)
Payment of debt issuance costs		—			(20	)		—			—			—			(20	)
Distributions to stockholders		(983	)		—			—			—			—			(983	)
Changes in intercompany balances with affiliates, net		675			1,239			(1,556	)		(358	)		—			—
Income tax benefits		82			—			—			—			—			82
Other		(37	)		—			—			2			—			(35	)
Net cash (used in) provided by financing activities		(263	)		1,090			(1,618	)		(682	)		—			(1,473	)
Change in cash and cash equivalents		—			—			34			65			—			99
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	149		$	323		$	—		$	472

28

HCA HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

NOTE 13 — SUBSEQUENT EVENT

On November 1, 2013, certain of the Company’s stockholders, consisting principally of affiliates of, or funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co. (the “Selling Stockholders”), sold in an underwritten secondary offering, 30 million shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholders received all of the proceeds from this offering. Concurrent with the closing of the secondary offering, the Company repurchased approximately $500 million of additional shares (approximately 10,656,400 shares) of its common stock from the Selling Stockholders at the net offering price ($46.92 per share).

29

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This quarterly report on Form 10-Q includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include statements regarding estimated electronic health record (“EHR”) incentive income and related EHR operating expenses, expected capital expenditures, expected net claim payments and all other statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), the possible delays in or complications related to implementation of the Health Reform Law, the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the continued implementation of the sequestration spending reductions required under the Budget Control Act of 2011 (the “BCA”) and the potential for future deficit reduction legislation that may alter BCA-mandated spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in the Medicare, Medicaid and other state programs, including Medicaid upper payment limit (“UPL”) programs or Waiver Programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) future divestitures which may result in charges and possible impairments of long-lived assets, (16) changes in business strategy or development plans, (17) delays in receiving payments for services provided, (18) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (20) our ongoing ability to demonstrate meaningful use of certified EHR technology and recognize income for the related Medicare or Medicaid incentive payments, and (21) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012 and our other filings with the Securities and Exchange Commission. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report, which forward-looking statements reflect management’s views only as of the date of this report. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

Health Care Reform

The Health Reform Law changes how health care services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending, reductions

30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Health Care Reform (continued)

in Medicare and Medicaid Disproportionate Share Hospital (“DSH”) payments, and the establishment of programs in which reimbursement is tied to quality and integration. In addition, the Health Reform Law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. The provisions of the Health Reform Law that seek to decrease the number of uninsured individuals mostly will become effective January 1, 2014. However, the federal online insurance marketplace has experienced significant technical issues that have negatively impacted the ability of individuals to enroll in Medicaid and to purchase health insurance. These technical issues, especially if not corrected in a timely manner, could lead to delays in the individual mandate tax penalties past the current March 31, 2014 deadline, delays in uninsured individuals obtaining health insurance and a reduction in the number of individuals choosing to purchase health insurance rather than paying the individual mandate tax penalties. The employer mandate, which requires firms with 50 or more full-time employees to offer health insurance or pay fines, has been delayed until January 1, 2015. In addition, a number of states have announced their intent to opt out of the Medicaid expansion, but these states could choose to implement the expansion at a later date. It is unclear how many states will ultimately decline to implement the Medicaid expansion provisions of the law. We are unable to predict with any reasonable certainty the likely impact of the Health Reform Law on our business model, financial condition or result of operations due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual and partially delayed implementation, court challenges and possible amendment, repeal or further implementation delays, as well as our inability to foresee how individuals, states and businesses will respond to the choices afforded them by the law.

Third Quarter 2013 Operations Summary

Revenues increased to $8.456 billion in the third quarter of 2013 from $8.062 billion in the third quarter of 2012. Net income attributable to HCA Holdings, Inc. totaled $365 million, or $0.79 per diluted share, for the quarter ended September 30, 2013, compared to $360 million, or $0.78 per diluted share, for the quarter ended September 30, 2012. Shares used for diluted earnings per share were 463.6 million shares for the quarter ended September 30, 2013 and 459.5 million shares for the quarter ended September 30, 2012.

Revenues increased 4.9% on a consolidated basis and increased 4.5% on a same facility basis for the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012. The increase in consolidated revenues can be attributed to the combined impact of a 3.9% increase in revenue per equivalent admission and a 0.9% increase in equivalent admissions. The same facility revenues increase resulted from the combined impact of a 3.4% increase in same facility revenue per equivalent admission and a 1.1% increase in same facility equivalent admissions.

During the quarter ended September 30, 2013, consolidated admissions and same facility admissions increased 0.5% and 0.7%, respectively, compared to the quarter ended September 30, 2012. Inpatient surgeries increased 3.4% on a consolidated basis and 2.9% on a same facility basis during the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012. Outpatient surgeries increased 1.5% on a consolidated basis and 0.4% on a same facility basis during the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012. Emergency department visits increased 0.8% on a consolidated basis and 0.9% on a same facility basis during the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012.

For the quarter ended September 30, 2013, the provision for doubtful accounts increased $124 million, compared to the quarter ended September 30, 2012. The self-pay revenue deductions for charity care and uninsured discounts increased $67 million and $185 million, respectively, during the third quarter of 2013, compared to the third quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, provision for doubtful accounts, uninsured discounts and

31

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Third Quarter 2013 Operations Summary (continued)

charity care, was 31.7% for the third quarter of 2013, compared to 30.5% for the third quarter of 2012. Same facility uninsured admissions increased 10.1% and same facility uninsured emergency room visits increased 2.9% for the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012.

Electronic health record incentive income declined $56 million, from $131 million in the third quarter of 2012 to $75 million in the third quarter of 2013. Interest expense increased $12 million to $458 million for the quarter ended September 30, 2013 from $446 million for the quarter ended September 30, 2012. The increase in interest expense was due to an increase in the average debt balance.

Cash flows from operating activities increased $245 million from $655 million for the third quarter of 2012 to $900 million for the third quarter of 2013. The increase is primarily related to the combined impact of favorable changes in working capital items of $136 million and a decline of $51 million in income taxes.

Results of Operations

Revenue/Volume Trends

Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis, fixed per diem rates or discounts from gross charges. We do not pursue collection of amounts related to patients who meet our guidelines to qualify for charity care; therefore, they are not reported in revenues. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. After the discounts are applied, we are still unable to collect a significant portion of uninsured patients’ accounts, and we record significant provisions for doubtful accounts (based upon our historical collection experience) related to uninsured patients in the period the services are provided.

32

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

Revenues increased 4.9% from $8.062 billion in the third quarter of 2012 to $8.456 billion in the third quarter of 2013. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from our third-party payers, the uninsured and other revenues for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following tables (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,847			21.8	%	$	1,949			24.2	%
Managed Medicare		794			9.4			720			8.9
Medicaid		401			4.7			378			4.7
Managed Medicaid		386			4.6			380			4.7
Managed care and other insurers		4,636			54.8			4,422			54.8
International (managed care and other insurers)		287			3.4			253			3.1
		8,351			98.7			8,102			100.4
Uninsured		717			8.5			576			7.1
Other		343			4.1			215			2.7
Revenues before provision for doubtful accounts		9,411			111.3			8,893			110.2
Provision for doubtful accounts		(955	)		(11.3	)		(831	)		(10.2	)
Revenues	$	8,456			100.0	%	$	8,062			100.0	%

	Nine Months
	2013			Ratio			2012			Ratio
Medicare	$	5,961			23.5	%	$	6,251			25.4	%
Managed Medicare		2,441			9.6			2,199			8.9
Medicaid		1,098			4.3			1,188			4.8
Managed Medicaid		1,165			4.6			1,080			4.4
Managed care and other insurers		13,777			54.4			13,340			54.3
International (managed care and other insurers)		868			3.4			779			3.2
		25,310			99.8			24,837			101.0
Uninsured		1,809			7.1			1,757			7.1
Other		959			3.8			651			2.7
Revenues before provision for doubtful accounts		28,078			110.7			27,245			110.8
Provision for doubtful accounts		(2,732	)		(10.7	)		(2,666	)		(10.8	)
Revenues	$	25,346			100.0	%	$	24,579			100.0	%

33

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

Medicare revenues for the nine months ended September 30, 2012 were impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the nine months ended September 30, 2012.

Consolidated and same facility revenue per equivalent admission increased 3.9% and 3.4%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility equivalent admissions increased 0.9% and 1.1%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility admissions increased 0.5% and 0.7%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility outpatient surgeries increased 1.5% and 0.4%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility inpatient surgeries increased 3.4% and 2.9%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility emergency department visits increased 0.8% and 0.9%, respectively, in the third quarter of 2013, compared to the third quarter of 2012.

To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view the direct uninsured revenue deductions and provision for doubtful accounts in combination, rather than each separately. At September 30, 2013, our allowance for doubtful accounts represented approximately 92% of the $5.525 billion total patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. A summary of these adjustments to revenues amounts, related to uninsured accounts, for the quarters and nine months ended September 30, 2013 and 2012 follows (dollars in millions):

	Quarter										Nine Months
	2013		Ratio			2012		Ratio			2013		Ratio			2012		Ratio
Charity care	$	876		22	%	$	809		23	%	$	2,578		23	%	$	2,340		23	%
Uninsured discounts		2,090		54			1,905		54			6,058		53			5,164		51
Provision for doubtful accounts		955		24			831		23			2,732		24			2,666		26
Totals	$	3,921		100	%	$	3,545		100	%	$	11,368		100	%	$	10,170		100	%

Same facility uninsured admissions increased by 3,484 admissions, or 10.1%, in the third quarter of 2013, compared to the third quarter of 2012. Same facility uninsured admissions increased 6.3% in the second quarter of 2013 and increased 5.4% in the first quarter of 2013, compared to the first and second quarters of 2012. Same facility uninsured admissions in 2012, compared to 2011, increased 11.0% in the fourth quarter of 2012, increased 7.3% in the third quarter of 2012, increased 8.9% in the second quarter of 2012 and increased 11.6% in the first quarter of 2012.

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are set forth in the following table.

	Quarter						Nine Months
	2013			2012			2013			2012
Medicare		31	%		32	%		32	%		33	%
Managed Medicare		13			12			13			12
Medicaid		8			8			8			8
Managed Medicaid		9			9			9			9
Managed care and other insurers		30			31			30			30
Uninsured		9			8			8			8
		100	%		100	%		100	%		100	%

The approximate percentages of our inpatient revenues, before provision for doubtful accounts, related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are set forth in the following table.

	Quarter						Nine Months
	2013			2012			2013			2012
Medicare		27	%		30	%		29	%		31	%
Managed Medicare		10			10			11			10
Medicaid		7			6			6			6
Managed Medicaid		4			4			4			4
Managed care and other insurers		47			46			46			45
Uninsured		5			4			4			4
		100	%		100	%		100	%		100	%

At September 30, 2013, we had 75 hospitals in the states of Texas and Florida. During the third quarter of 2013, 55% of our admissions and 46% of our revenues were generated by these hospitals. Uninsured admissions in Texas and Florida represented 63% of our uninsured admissions during the third quarter of 2013.

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. In 2011, the Centers for Medicare and Medicaid Services (“CMS”) approved a Medicaid waiver that allows Texas to continue receiving supplemental Medicaid reimbursement while expanding its Medicaid managed care program. Thus, Texas is operating pursuant to a Waiver Program. The Texas Waiver Program includes two primary components: the continuation of an indigent care component and the establishment of a Delivery System Reform Incentive Payment (“DSRIP”) component. Initiatives under the DSRIP program are designed to provide incentive payments to hospitals and other providers for their investments in delivery system reforms that increase access to health care, improve the quality of care and enhance the health of patients and families they serve. We provide indigent care services in several communities in the state of Texas, in affiliation with other hospitals. The state of Texas has been involved in efforts to increase the indigent care provided by private hospitals. As a result of additional indigent care being provided by private hospitals, public hospital districts or counties in Texas have available funds that were previously devoted to indigent care. The public hospital districts or counties are under no contractual or legal obligation to provide such indigent care.

35

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Revenue/Volume Trends (continued)

The public hospital districts or counties have elected to transfer some portion of these available funds to the state’s Medicaid program. Such action is at the sole discretion of the public hospital districts or counties. It is anticipated that these contributions to the state will be matched with federal Medicaid funds. The state then may make supplemental payments to hospitals in the state for Medicaid services rendered. Hospitals receiving Medicaid supplemental payments may include those that are providing additional indigent care services. Our Texas Medicaid revenues included $124 million ($38 million DSRIP related and $86 million indigent care related) and $110 million (all indigent care related) during the third quarters of 2013 and 2012, respectively, and $275 million ($50 million DSRIP related and $225 million indigent care related) and $350 million (all indigent care related) during the first nine months of 2013 and 2012, respectively, of Medicaid supplemental payments. In addition, we receive supplemental payments in several other states. We are aware these supplemental payment programs are currently being reviewed by certain state agencies and some states have made waiver requests to CMS to replace their existing supplemental payment programs. It is possible these reviews and waiver requests will result in the restructuring of such supplemental payment programs and could result in the payment programs being reduced or eliminated. Because deliberations about these programs are ongoing, we are unable to estimate the financial impact the program structure modifications, if any, may have on our results of operations.

Electronic Health Record Incentive Payments

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments for eligible hospitals and professionals that adopt and meaningfully use certified EHR technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

We recognized $75 million ($48 million Medicare and $27 million Medicaid) and $131 million ($52 million Medicare and $79 million Medicaid) of electronic health record incentive income during the third quarters of 2013 and 2012, respectively. We recognized $166 million ($139 million Medicare and $27 million Medicaid) and $256 million ($174 million Medicare and $82 million Medicaid) of electronic health record incentive income during the first nine months of 2013 and 2012, respectively.

We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of recognizing the expenses may not correlate with the receipt of the incentive payments and the recognition of revenues. We incurred $26 million and $24 million during the third quarters of 2013 and 2012, respectively, and $85 million and $61 million during the first nine months of 2013 and 2012, respectively, of operating expenses to implement our certified EHR technology and meet meaningful use.

For 2013, we estimate EHR incentive income will be recognized in the range of $200 million to $225 million and that related EHR operating expenses will be in the range of $120 million to $140 million. Actual incentive payments and EHR operating expenses could vary from these estimates due to certain factors such as availability of federal funding for both Medicare and Medicaid incentive payments and our ability to continue to demonstrate meaningful use of certified EHR technology. The failure of our ability to continue to demonstrate meaningful use of EHR technology could have a material, adverse effect on our results of operations.

36

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Operating Results Summary

The following is a comparative summary of results from operations for the quarters and nine months ended September 30, 2013 and 2012 (dollars in millions):

	Quarter
	2013						2012
	Amount			Ratio			Amount			Ratio
Revenues before provision for doubtful accounts	$	9,411					$	8,893
Provision for doubtful accounts		955						831
Revenues		8,456			100.0			8,062			100.0
Salaries and benefits		3,916			46.3			3,781			46.9
Supplies		1,457			17.2			1,375			17.1
Other operating expenses		1,564			18.5			1,510			18.7
Electronic health record incentive income		(75	)		(0.9	)		(131	)		(1.6	)
Equity in earnings of affiliates		(9	)		(0.1	)		(6	)		(0.1	)
Depreciation and amortization		443			5.3			417			5.2
Interest expense		458			5.4			446			5.5
Losses (gains) on sales of facilities		1			—			(7	)		(0.1	)
		7,755			91.7			7,385			91.6
Income before income taxes		701			8.3			677			8.4
Provision for income taxes		234			2.8			222			2.8
Net income		467			5.5			455			5.6
Net income attributable to noncontrolling interests		102			1.2			95			1.1
Net income attributable to HCA Holdings, Inc.	$	365			4.3		$	360			4.5
% changes from prior year:
Revenues		4.9	%					11.1	%
Income before income taxes		3.6						450.6
Net income attributable to HCA Holdings, Inc.		1.5						493.2
Admissions(a)		0.5						7.0
Equivalent admissions(b)		0.9						8.3
Revenue per equivalent admission		3.9						2.5
Same facility % changes from prior year(c):
Revenues		4.5						3.3
Admissions(a)		0.7						2.1
Equivalent admissions(b)		1.1						2.6
Revenue per equivalent admission		3.4						0.7

37

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Operating Results Summary (continued)

	Nine Months
	2013						2012
	Amount			Ratio			Amount			Ratio
Revenues before provision for doubtful accounts	$	28,078					$	27,245
Provision for doubtful accounts		2,732						2,666
Revenues		25,346			100.0			24,579			100.0
Salaries and benefits		11,681			46.1			11,224			45.7
Supplies		4,406			17.4			4,216			17.2
Other operating expenses		4,594			18.1			4,496			18.2
Electronic health record incentive income		(166	)		(0.7	)		(256	)		(1.0	)
Equity in earnings of affiliates		(29	)		(0.1	)		(26	)		(0.1	)
Depreciation and amortization		1,292			5.0			1,254			5.1
Interest expense		1,392			5.5			1,336			5.4
Losses (gains) on sales of facilities		13			0.1			(4	)		—
Loss on retirement of debt		17			0.1			—			—
		23,200			91.5			22,240			90.5
Income before income taxes		2,146			8.5			2,339			9.5
Provision for income taxes		704			2.8			760			3.1
Net income		1,442			5.7			1,579			6.4
Net income attributable to noncontrolling interests		310			1.2			288			1.1
Net income attributable to HCA Holdings, Inc.	$	1,132			4.5		$	1,291			5.3
% changes from prior year:
Revenues		3.1	%					12.2	%
Income before income taxes		(8.2	)					111.3
Net income attributable to HCA Holdings, Inc.		(12.3	)					143.6
Admissions(a)		0.6						7.9
Equivalent admissions(b)		0.5						9.8
Revenue per equivalent admission		2.6						2.2
Same facility % changes from prior year(c):
Revenues		2.9						4.1
Admissions(a)		0.7						2.6
Equivalent admissions(b)		0.5						3.8
Revenue per equivalent admission		2.3						0.3

(a) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(b) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(c) Same facility information excludes the operations of hospitals and their related facilities which were either acquired or divested during the current and prior period.

38

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended September 30, 2013 and 2012

Net income attributable to HCA Holdings, Inc. totaled $365 million, or $0.79 per diluted share, for the third quarter of 2013 compared to $360 million, or $0.78 per diluted share, for the third quarter of 2012. Third quarter 2012 results include net gains on sales of facilities of $7 million, or $0.01 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 463.6 million shares and 459.5 million shares for the quarters ended September 30, 2013 and 2012, respectively.

For the third quarter of 2013, consolidated and same facility admissions increased 0.5% and 0.7%, respectively, compared to the third quarter of 2012. Consolidated and same facility outpatient surgical volumes increased 1.5% and 0.4%, respectively, during the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility inpatient surgeries increased 3.4% and 2.9%, respectively, in the third quarter of 2013, compared to the third quarter of 2012. Consolidated and same facility emergency department visits increased 0.8% and 0.9%, respectively, during the quarter ended September 30, 2013, compared to the quarter ended September 30, 2012.

Revenues before provision for doubtful accounts increased 5.8% for the third quarter of 2013 compared to the third quarter of 2012. Provision for doubtful accounts increased $124 million from $831 million in the third quarter of 2012 to $955 million in the third quarter of 2013. The provision for doubtful accounts relates primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $67 million and $185 million, respectively, during the third quarter of 2013, compared to the third quarter of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 31.7% for the third quarter of 2013, compared to 30.5% for the third quarter of 2012. At September 30, 2013, our allowance for doubtful accounts represented approximately 92% of the $5.525 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 4.9% primarily due to the combined impact of revenue per equivalent admission growth of 3.9% and a 0.9% increase in equivalent admissions for the third quarter of 2013 compared to the third quarter of 2012. Same facility revenues increased 4.5% due to the combined impact of a 3.4% increase in same facility revenue per equivalent admission and a 1.1% increase in same facility equivalent admissions for the third quarter of 2013 compared to the third quarter of 2012.

Salaries and benefits, as a percentage of revenues, were 46.3% in the third quarter of 2013 and 46.9% in the third quarter of 2012. Salaries and benefits per equivalent admission increased 2.6% in the third quarter of 2013 compared to the third quarter of 2012. Same facility labor rate increases averaged 2.0% for the third quarter of 2013 compared to the third quarter of 2012.

Supplies, as a percentage of revenues, were 17.2% in the third quarter of 2013 and 17.1% in the third quarter of 2012. Supply cost per equivalent admission increased 4.9% in the third quarter of 2013 compared to the third quarter of 2012. Supply costs per equivalent admission increased 8.0% for medical devices, 0.6% for pharmacy supplies and 5.5% for general medical and surgical items in the third quarter of 2013 compared to the third quarter of 2012.

Other operating expenses, as a percentage of revenues, declined to 18.5% in the third quarter of 2013 from 18.7% in the third quarter of 2012. Other operating expenses is primarily comprised of contract services,

39

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Quarters Ended September 30, 2013 and 2012 (continued)

professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Provisions for losses related to professional liability risks were $78 million and $59 million for the third quarters of 2013 and 2012, respectively.

We recognized $75 million ($48 million Medicare and $27 million Medicaid) and $131 million ($52 million Medicare and $79 million Medicaid) of electronic health record incentive income primarily related to Medicare incentives during the third quarters of 2013 and 2012, respectively.

Equity in earnings of affiliates was $9 million and $6 million in the third quarters of 2013 and 2012, respectively.

Depreciation and amortization increased $26 million, from $417 million in the third quarter of 2012 to $443 million in the third quarter of 2013. The increase was related primarily to several construction projects being completed during the second and third quarters of 2013.

Interest expense increased from $446 million in the third quarter of 2012 to $458 million in the third quarter of 2013. The increase in interest expense was due to an increase in the average debt balance. Our average debt balance was $28.177 billion for the third quarter of 2013 compared to $26.685 billion for the third quarter of 2012. The average effective interest rate for our long term debt declined from 6.6% for the quarter ended September 30, 2012 to 6.4% for the quarter ended September 30, 2013.

During the third quarters of 2013 and 2012, we recorded net losses on sales of facilities of $1 million and net gains on sales of facilities of $7 million, respectively.

The effective tax rates were 39.1% and 38.2% for the third quarters of 2013 and 2012, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships.

Net income attributable to noncontrolling interests increased from $95 million for the third quarter of 2012 to $102 million for the third quarter of 2013. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.

Nine Months Ended September 30, 2013 and 2012

Net income attributable to HCA Holdings, Inc. totaled $1.132 billion, or $2.44 per diluted share, in the nine months ended September 30, 2013 compared to $1.291 billion, or $2.81 per diluted share, in the nine months ended September 30, 2012. The first nine months of 2013 results include net losses on sales of facilities of $13 million, or $0.02 per diluted share, and a loss on retirement of debt of $17 million, or $0.02 per diluted share. The first nine months of 2012 results include two Medicare revenue adjustments (and related expenses) that added $170 million to income before income taxes, or $0.22 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 463.1 million shares and 458.8 million shares for the nine months ended September 30, 2013 and 2012, respectively.

For the first nine months of 2013, consolidated and same facility admissions increased 0.6% and 0.7%, respectively, compared to the first nine months of 2012. Consolidated and same facility outpatient surgical volumes declined 0.1% and 1.3%, respectively, during the first nine months of 2013, compared to the first nine

40

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Nine Months Ended September 30, 2013 and 2012 (continued)

months of 2012. Consolidated and same facility inpatient surgeries each increased 0.1% in the first nine months of 2013, compared to the first nine months of 2012. Consolidated and same facility emergency department visits increased 1.7% and 1.8%, respectively, during the nine months ended September 30, 2013, compared to the nine months ended September 30, 2012.

Revenues before provision for doubtful accounts increased 3.1% for the first nine months of 2013 compared to the first nine months of 2012. Provision for doubtful accounts increased $66 million from $2.666 billion in the first nine months of 2012 to $2.732 billion in the first nine months of 2013. The provision for doubtful accounts relates primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $238 million and $894 million, respectively, during the first nine months of 2013, compared to the first nine months of 2012. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 31.0% for the first nine months of 2013, compared to 29.3% for the first nine months of 2012. At September 30, 2013, our allowance for doubtful accounts represented approximately 92% of the $5.525 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 3.1% due to the combined impact of revenue per equivalent admission growth of 2.6% and an increase of 0.5% in equivalent admissions for the first nine months of 2013 compared to the first nine months of 2012. Same facility revenues increased 2.9% due to the combined impact of a 2.3% increase in same facility revenue per equivalent admission and a 0.5% increase in same facility equivalent admissions for the first nine months of 2013 compared to the first nine months of 2012.

Salaries and benefits, as a percentage of revenues, were 46.1% in the first nine months of 2013 and 45.7% in the first nine months of 2012. Salaries and benefits per equivalent admission increased 3.5% in the first nine months of 2013 compared to the first nine months of 2012. Same facility labor rate increases averaged 1.9% for the first nine months of 2013 compared to the first nine months of 2012.

Supplies, as a percentage of revenues, were 17.4% in the first nine months of 2013 and 17.2% in the first nine months of 2012. Supply cost per equivalent admission increased 4.0% in the first nine months of 2013 compared to the first nine months of 2012. Supply costs per equivalent admission increased 5.8% for medical devices and 5.4% for general medical and surgical items and declined 0.8% for pharmacy supplies in the first nine months of 2013 compared to the first nine months of 2012.

Other operating expenses, as a percentage of revenues, declined to 18.1% in the first nine months of 2013 from 18.2% in the first nine months of 2012. Other operating expenses is primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Provisions for losses related to professional liability risks were $237 million and $230 million for the first nine months of 2013 and 2012, respectively.

We recognized $166 million ($139 million Medicare and $27 million Medicaid) and $256 million ($174 million Medicare and $82 million Medicaid) of electronic health record incentive income primarily related to Medicare incentives during the first nine months of 2013 and 2012, respectively.

Equity in earnings of affiliates was $29 million and $26 million in the first nine months of 2013 and 2012.

41

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Results of Operations (continued)

Nine Months Ended September 30, 2013 and 2012 (continued)

Depreciation and amortization increased $38 million, from $1.254 billion in the first nine months of 2012 to $1.292 billion in the first nine months of 2013.

Interest expense increased from $1.336 billion in the first nine months of 2012 to $1.392 billion in the first nine months of 2013 due to an increase in the average debt balance. Our average debt balance was $28.385 billion for the first nine months of 2013 compared to $27.211 billion for the first nine months of 2012. The average effective interest rate for our long term debt was 6.6% for each of the nine months ended September 30, 2013 and 2012.

During the first nine months of 2013 and 2012, we recorded net losses on sales of facilities of $13 million and net gains on sales of facilities of $4 million, respectively.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

The effective tax rates were 38.3% and 37.1% for the first nine months of 2013 and 2012, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships.

Net income attributable to noncontrolling interests increased from $288 million for the first nine months of 2012 to $310 million for the first nine months of 2013. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.

Liquidity and Capital Resources

Cash provided by operating activities totaled $2.454 billion in the first nine months of 2013 compared to $2.912 billion in the first nine months of 2012. The $458 million decline in cash provided by operating activities in the first nine months of 2013 compared to the first nine months of 2012 related primarily to a decline in net income of $137 million and a negative impact from changes in working capital items of $330 million. The combined interest payments and net tax payments in the first nine months of 2013 and 2012 were $1.940 billion and $1.832 billion, respectively. Working capital totaled $2.352 billion at September 30, 2013 and $1.591 billion at December 31, 2012.

Cash used in investing activities was $1.674 billion in the first nine months of 2013 compared to $1.340 billion in the first nine months of 2012. Excluding acquisitions, capital expenditures were $1.347 billion in the first nine months of 2013 and $1.268 billion in the first nine months of 2012. During the first nine months of 2013, we expended $278 million for the acquisition of The Outsource Group and $146 million for three hospitals that became effective October 1, 2013. We also expended $39 million to acquire nonhospital health care facilities during the first nine months of 2013. We expended $58 million for the acquisition of a hospital facility and $109 million to acquire nonhospital health care facilities during the first nine months of 2012. Capital expenditures, excluding acquisitions, are expected to approximate $2.0 billion in 2013. At September 30, 2013, there were projects under construction which had estimated additional costs to complete and equip over the next five years of approximately $1.60 billion. We expect to finance capital expenditures with internally generated and borrowed funds. We received $31 million and $17 million from sales of health care entities during the first nine months of 2013 and 2012, respectively. We received net cash flows from our investments of $97 million and $73 million in the first nine months of 2013 and 2012, respectively.

42

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Cash used in financing activities totaled $1.001 billion during the first nine months of 2013 compared to $1.473 billion during the first nine months of 2012. During the first nine months of 2013, net cash flows used in financing activities included net debt repayments of $670 million, distributions to noncontrolling interests of $308 million, distributions to stockholders of $13 million and receipts of $70 million of income tax benefits for certain items (primarily related to employee exercises of stock options). During the first nine months of 2012, net cash flows used in financing activities included net debt repayments of $214 million, distributions to noncontrolling interests of $303 million, distributions to stockholders of $983 million and receipts of $82 million of income tax benefits for certain items (primarily distributions to holders of our stock options).

We are a highly leveraged company with significant debt service requirements. Our debt totaled $28.377 billion at September 30, 2013. Our interest expense was $1.392 billion for the first nine months of 2013 and $1.336 billion for the first nine months of 2012. The increase in interest expense was due to the increase in the average debt balance.

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($2.334 billion and $2.594 billion available as of September 30, 2013 and October 31, 2013, respectively) and anticipated access to public and private debt markets.

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

Investments of our professional liability insurance subsidiaries, to maintain statutory equity and pay claims, totaled $465 million and $570 million at September 30, 2013 and December 31, 2012, respectively. An insurance subsidiary maintained net reserves for professional liability risks of $313 million and $352 million at September 30, 2013 and December 31, 2012, respectively. Our facilities are insured by a 100% owned insurance subsidiary for losses up to $50 million per occurrence; however, this coverage is subject to a $5 million per occurrence self-insured retention. Net reserves for the self-insured professional liability risks retained were $949 million and $896 million at September 30, 2013 and December 31, 2012, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $321 million. We estimate that approximately $258 million of the expected net claim payments during the next 12 months will relate to claims subject to the self-insured retention.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next 12 months.

Market Risk

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our 100% owned insurance subsidiaries were $462 million and $3 million, respectively, at September 30, 2013. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At September 30, 2013, we had a net unrealized gain of $11 million on the insurance subsidiaries’ investment securities.

We are exposed to market risk related to market illiquidity. Investments in debt and equity securities of our 100% owned insurance subsidiaries could be impaired by the inability to access the capital markets. Should the 100% owned insurance subsidiaries require significant amounts of cash in excess of normal cash requirements to

43

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Liquidity and Capital Resources (continued)

Market Risk (continued)

pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. We may be required to recognize other-than-temporary impairments on our investment securities in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue-specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income, and changes in the fair value of derivatives which have not been designated as hedges are recorded in operations.

With respect to our interest-bearing liabilities, approximately $3.545 billion of long-term debt at September 30, 2013 was subject to variable rates of interest, while the remaining balance in long-term debt of $24.832 billion at September 30, 2013 was subject to fixed rates of interest. Both the general level of interest rates and, for the senior secured credit facilities, our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% and (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt was 6.6% for each of the nine months ended September 30, 2013 and 2012.

The estimated fair value of our total long-term debt was $29.492 billion at September 30, 2013. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $35 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

Our international operations and the European term loan expose us to market risks associated with foreign currencies. In order to mitigate the currency exposure related to debt service obligations under the European term loan, we have entered into a cross currency swap agreement. A cross currency swap is an agreement between two parties to exchange a stream of principal and interest payments in one currency for a stream of principal and interest payments in another currency over a specified period. Our credit risk related to this agreement is considered low because the swap agreement is with a creditworthy financial institution.

IRS Examinations

We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2011 federal income tax return in 2014.

44

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

IRS Examinations (continued)

Management believes HCA Holdings, Inc. and its affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and final resolution of any disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of any issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.

45

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data

	2013		2012
Number of hospitals in operation at:
March 31		162		164
June 30		161		163
September 30		162		162
December 31				162
Number of freestanding outpatient surgical centers in operation at:
March 31		113		109
June 30		114		110
September 30		114		112
December 31				112
Licensed hospital beds at(a):
March 31		41,891		41,815
June 30		41,792		41,817
September 30		42,038		41,884
December 31				41,804
Weighted average licensed beds(b):
Quarter:
First		41,867		41,740
Second		41,842		41,789
Third		42,005		41,873
Fourth				41,777
Year				41,795
Average daily census(c):
Quarter:
First		24,147		23,284
Second		22,523		22,113
Third		22,099		22,122
Fourth				22,567
Year				22,521
Admissions(d):
Quarter:
First		444,200		443,300
Second		433,000		428,200
Third		432,600		430,500
Fourth				438,700
Year				1,740,700
Equivalent admissions(e):
Quarter:
First		708,000		711,100
Second		708,700		700,800
Third		711,800		705,200
Fourth				715,000
Year				2,832,100

46

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

	2013			2012
Average length of stay (days)(f):
Quarter:
First		4.9			4.8
Second		4.7			4.7
Third		4.7			4.7
Fourth					4.7
Year					4.7
Emergency room visits(g):
Quarter:
First		1,749,300			1,688,400
Second		1,726,400			1,714,200
Third		1,738,100			1,724,000
Fourth					1,785,400
Year					6,912,000
Outpatient surgeries(h):
Quarter:
First		211,100			217,500
Second		222,200			219,800
Third		215,600			212,300
Fourth					224,000
Year					873,600
Inpatient surgeries(i):
Quarter:
First		124,700			128,300
Second		126,500			126,700
Third		128,900			124,700
Fourth					126,800
Year					506,500
Days revenues in accounts receivable(j):
Quarter:
First		52			53
Second		53			50
Third		54			52
Fourth					51
Year					52
Gross patient revenues(k) (dollars in millions):
Quarter:
First	$	44,791		$	41,377
Second		44,203			40,327
Third		43,945			40,125
Fourth					43,785
Year					165,614
Outpatient revenues as a % of patient revenues(l):
Quarter:
First		37	%		37	%
Second		38	%		39	%
Third		38	%		38	%
Fourth					39	%
Year					38	%

47

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS (continued)

Operating Data—(continued)

BALANCE SHEET DATA

	% of Accounts Receivable
	Under 91 Days			91 — 180 Days			Over 180 Days
Accounts receivable aging at September 30, 2013 (m):
Medicare and Medicaid		13	%		1	%		2	%
Managed care and other discounted		20			4			5
Uninsured		19			9			27
Total		52	%		14	%		34	%

(a) Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(b) Represents the average number of licensed beds, weighted based on periods owned.

(c) Represents the average number of patients in our hospital beds each day.

(d) Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(e) Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenues and gross outpatient revenues and then dividing the resulting amount by gross inpatient revenues. The equivalent admissions computation “equates” outpatient revenues to the volume measure (admissions) used to measure inpatient volume resulting in a general measure of combined inpatient and outpatient volume.

(f) Represents the average number of days admitted patients stay in our hospitals.

(g) Represents the number of patients treated in our emergency rooms.

(h) Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(i) Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(j) Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of allowance for doubtful accounts, at the end of the period divided by the revenues per day.

(k) Gross patient revenues are based upon our standard charge listing. Gross charges/revenues typically do not reflect what our hospital facilities are paid. Gross charges/revenues are reduced by contractual adjustments, discounts and charity care to determine reported revenues.

(l) Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.

(m) Accounts receivable aging data is based upon consolidated gross accounts receivable of $10.029 billion (each 1% is equivalent to approximately $100 million of gross accounts receivable).

48

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The information called for by this item is provided under the caption “Market Risk” under Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

HCA’s chief executive officer and chief financial officer have reviewed and evaluated the effectiveness of HCA’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of the end of the period covered by this quarterly report. Based on that evaluation, the chief executive officer and chief financial officer have concluded HCA’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

During the period covered by this report, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially and adversely affect our results of operations and financial position in a given period.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the DOJ has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing

49

medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action had also been stayed pending developments in the shareholder class actions, but that stay has expired. The plaintiff in the state derivative action subsequently filed an amended complaint on September 9, 2013 that added additional allegations made in the shareholder class actions. The Company has filed a motion to again stay the state derivative action pending developments in the class action but the Court has not yet acted on that motion. On September 24, 2013, an additional state derivative action, Steinberg v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court. This action against our board of directors is substantially similar to the earlier filed state derivative action and the Company is attempting to consolidate the two state actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals

50

from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

General Liability and Other Claims

We are subject to claims for additional income taxes and related interest. For a description of those proceedings, see Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — IRS Examinations” and Note 3 to our condensed consolidated financial statements.

We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

ITEM 1A. RISK FACTORS

Reference is made to the factors set forth under the caption “Forward-Looking Statements” in Part I, Item 2 of this Form 10-Q and other risk factors described in our annual report on Form 10-K for the year ended December 31, 2012, which are incorporated herein by reference. There have not been any material changes to the risk factors previously disclosed in our annual report on Form 10-K for the year ended December 31, 2012.

ITEM 6. EXHIBITS

(a) List of Exhibits:

31.1	—	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	—	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	—	Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101	—	The following financial information from our quarterly report on Form 10-Q for the quarters ended September 30, 2013 and 2012, filed with the SEC on November 6, 2013, formatted in Extensible Business Reporting Language: (i) the condensed consolidated balance sheets at September 30, 2013 and December 31, 2012, (ii) the condensed consolidated income statements for the quarters and nine months ended September 30, 2013 and 2012, (iii) the condensed consolidated comprehensive income statements for the quarters and nine months ended September 30, 2013 and 2012, (iv) the condensed consolidated statements of cash flows for the nine months ended September 30, 2013 and 2012 and (v) the notes to condensed consolidated financial statements.

51

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

HCA Holdings, Inc.
By:	/S/    R. MILTON JOHNSON
	R. Milton Johnson
	President and Chief Financial Officer

Date: November 6, 2013

52

EX-31.1

EXHIBIT 31.1

CERTIFICATION

I, Richard M. Bracken, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

Date: November 6, 2013

EX-31.2

EXHIBIT 31.2

CERTIFICATION

I, R. Milton Johnson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of HCA Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

By:	/s/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

Date: November 6, 2013

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HCA Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

By:	/s/    RICHARD M. BRACKEN
	RICHARD M. BRACKEN
	Chairman of the Board and Chief Executive Officer

November 6, 2013

By:	/s/    R. MILTON JOHNSON
	R. MILTON JOHNSON
	President and Chief Financial Officer

November 6, 2013

XML

Segment and Geographic Information

9 Months Ended

Sep. 30, 2013

Segment Reporting [Abstract]

Segment and Geographic Information

NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 77 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 79 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, loss on retirement of debt, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Nine Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,930		$	3,755		$	11,875		$	11,553
American Group		4,082			3,982			12,181			12,033
Corporate and other		444			325			1,290			993
	$	8,456		$	8,062		$	25,346		$	24,579
Equity in earnings of affiliates:
National Group	$	(3	)	$	—		$	(8	)	$	(7	)
American Group		(6	)		(6	)		(19	)		(20	)
Corporate and other		—			—			(2	)		1
	$	(9	)	$	(6	)	$	(29	)	$	(26	)
Adjusted segment EBITDA:
National Group	$	805		$	768		$	2,440		$	2,478
American Group		910			843			2,654			2,657
Corporate and other		(112	)		(78	)		(234	)		(210	)
	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization:
National Group	$	181		$	171		$	532		$	520
American Group		206			207			610			612
Corporate and other		56			39			150			122
	$	443		$	417		$	1,292		$	1,254
Adjusted segment EBITDA	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization		443			417			1,292			1,254
Interest expense		458			446			1,392			1,336
Losses (gains) on sales of facilities		1			(7	)		13			(4	)
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	701		$	677		$	2,146		$	2,339

XML

Segment and Geographic Information - Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Revenues		$ 8,456	$ 8,062	$ 25,346	$ 24,579
Equity in earnings of affiliates		(9)	(6)	(29)	(26)
Adjusted segment EBITDA		1,603	1,533	4,860	4,925
Depreciation and amortization		443	417	1,292	1,254
Adjusted segment EBITDA		1,603	1,533	4,860	4,925
Depreciation and amortization		443	417	1,292	1,254
Interest expense		458	446	1,392	1,336
Losses (gains) on sales of facilities		1	(7)	13	(4)
Loss on retirement of debt	17			17
Income before income taxes		701	677	2,146	2,339
National Group [Member]
Segment Reporting Information [Line Items]
Revenues		3,930	3,755	11,875	11,553
Equity in earnings of affiliates		(3)		(8)	(7)
Adjusted segment EBITDA		805	768	2,440	2,478
Depreciation and amortization		181	171	532	520
Adjusted segment EBITDA		805	768	2,440	2,478
Depreciation and amortization		181	171	532	520
American Group [Member]
Segment Reporting Information [Line Items]
Revenues		4,082	3,982	12,181	12,033
Equity in earnings of affiliates		(6)	(6)	(19)	(20)
Adjusted segment EBITDA		910	843	2,654	2,657
Depreciation and amortization		206	207	610	612
Adjusted segment EBITDA		910	843	2,654	2,657
Depreciation and amortization		206	207	610	612
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Revenues		444	325	1,290	993
Equity in earnings of affiliates				(2)	1
Adjusted segment EBITDA		(112)	(78)	(234)	(210)
Depreciation and amortization		56	39	150	122
Adjusted segment EBITDA		(112)	(78)	(234)	(210)
Depreciation and amortization		$ 56	$ 39	$ 150	$ 122

XML

Condensed Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 484	$ 705
Accounts receivable, less allowance for doubtful accounts of $5,105 and $4,846	4,924	4,672
Inventories	1,135	1,086
Deferred income taxes	400	385
Other	828	915
Total current assets	7,771	7,763
Property and equipment, at cost	30,472	29,527
Accumulated depreciation	(17,150)	(16,342)
Property and equipment, net	13,322	13,185
Investments of insurance subsidiaries	402	515
Investments in and advances to affiliates	125	104
Goodwill and other intangible assets	5,832	5,539
Deferred loan costs	250	290
Other	691	679
Total assets	28,393	28,075
Current liabilities:
Accounts payable	1,582	1,768
Accrued salaries	1,085	1,120
Other accrued expenses	1,764	1,849
Long-term debt due within one year	988	1,435
Total current liabilities	5,419	6,172
Long-term debt	27,389	27,495
Professional liability risks	959	973
Income taxes and other liabilities	1,670	1,776
Stockholders' deficit:
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 447,573,400 shares in 2013 and 443,200,200 shares in 2012	4	4
Capital in excess of par value	1,821	1,753
Accumulated other comprehensive loss	(374)	(457)
Retained deficit	(9,827)	(10,960)
Stockholders' deficit attributable to HCA Holdings, Inc.	(8,376)	(9,660)
Noncontrolling interests	1,332	1,319
Total stockholders' deficit	(7,044)	(8,341)
Total liabilities and stockholders' deficit	$ 28,393	$ 28,075

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Earnings Per Share

NOTE 4 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share for the quarters and nine months ended September 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Nine Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	365	$	360	$	1,132	$	1,291
Weighted average common shares outstanding		447,329		440,899		446,125		439,441
Effect of dilutive incremental shares		16,240		18,616		16,926		19,381
Shares used for diluted earnings per share		463,569		459,515		463,051		458,822
Earnings per share:
Basic earnings per share	$	0.82	$	0.82	$	2.54	$	2.94
Diluted earnings per share	$	0.79	$	0.78	$	2.44	$	2.81

XML

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2013

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at September 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(6	)
Pay-fixed interest rate swaps		3,000		December 2016		(269	)
Pay-fixed interest rate swaps		1,000		December 2017		(48	)

Schedule of Cross Currency Swap Agreement Not Designated as Hedge

Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at September 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(4	)

Effect of Interest Rate and Cross Currency Swaps on Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the nine months ended September 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	6		Interest expense	$	97

Derivatives — Results of Operations (continued)

Derivatives Not Designated as Hedging Instruments	Location of Gain Recognized in Operations on Derivatives		Amount of Gain Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Balance Sheet (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012	Sep. 30, 2012	Dec. 31, 2011
Current assets:
Cash and cash equivalents	$ 484	$ 705	$ 472	$ 373
Accounts receivable, net	4,924	4,672
Inventories	1,135	1,086
Deferred income taxes	400	385
Other	828	915
Total current assets	7,771	7,763
Property and equipment, net	13,322	13,185
Investments of insurance subsidiaries	402	515
Investments in and advances to affiliates	125	104
Goodwill and other intangible assets	5,832	5,539
Deferred loan costs	250	290
Other	691	679
Total assets	28,393	28,075
Current liabilities:
Accounts payable	1,582	1,768
Accrued salaries	1,085	1,120
Other accrued expenses	1,764	1,849
Long-term debt due within one year	988	1,435
Total current liabilities	5,419	6,172
Long-term debt	27,389	27,495
Intercompany balances
Professional liability risks	959	973
Income taxes and other liabilities	1,670	1,776
Total liabilities	35,437	36,416
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(8,376)	(9,660)
Noncontrolling interests	1,332	1,319
Total stockholders' deficit	(7,044)	(8,341)
Total liabilities and stockholders' deficit	28,393	28,075
HCA Holdings, Inc. Issuer [Member]
Current assets:
Cash and cash equivalents		22
Accounts receivable, net
Inventories
Deferred income taxes	400	385
Other	6	122
Total current assets	406	529
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates	19,784	18,481
Goodwill and other intangible assets
Deferred loan costs	30	32
Other	315	469
Total assets	20,535	19,511
Current liabilities:
Accounts payable	1
Accrued salaries
Other accrued expenses	255	30
Long-term debt due within one year
Total current liabilities	256	30
Long-term debt	2,525	2,525
Intercompany balances	25,682	26,131
Professional liability risks
Income taxes and other liabilities	448	485
Total liabilities	28,911	29,171
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(8,376)	(9,660)
Noncontrolling interests
Total stockholders' deficit	(8,376)	(9,660)
Total liabilities and stockholders' deficit	20,535	19,511
HCA Inc. Issuer [Member]
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Deferred income taxes
Other
Total current assets
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates
Goodwill and other intangible assets
Deferred loan costs	220	258
Other
Total assets	220	258
Current liabilities:
Accounts payable
Accrued salaries
Other accrued expenses	259	567
Long-term debt due within one year	906	1,360
Total current liabilities	1,165	1,927
Long-term debt	24,174	24,304
Intercompany balances	(10,477)	(12,407)
Professional liability risks
Income taxes and other liabilities	327	442
Total liabilities	15,189	14,266
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(14,969)	(14,008)
Noncontrolling interests
Total stockholders' deficit	(14,969)	(14,008)
Total liabilities and stockholders' deficit	220	258
Subsidiary Guarantors [Member]
Current assets:
Cash and cash equivalents	167	383	149	115
Accounts receivable, net	2,481	2,448
Inventories	667	629
Deferred income taxes
Other	327	342
Total current assets	3,642	3,802
Property and equipment, net	7,467	7,417
Investments of insurance subsidiaries
Investments in and advances to affiliates	15	16
Goodwill and other intangible assets	1,695	1,697
Deferred loan costs
Other	37	31
Total assets	12,856	12,963
Current liabilities:
Accounts payable	1,012	1,203
Accrued salaries	634	638
Other accrued expenses	441	464
Long-term debt due within one year	43	39
Total current liabilities	2,130	2,344
Long-term debt	165	173
Intercompany balances	(18,677)	(17,130)
Professional liability risks
Income taxes and other liabilities	639	629
Total liabilities	(15,743)	(13,984)
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	28,484	26,847
Noncontrolling interests	115	100
Total stockholders' deficit	28,599	26,947
Total liabilities and stockholders' deficit	12,856	12,963
Subsidiary Non-Guarantors [Member]
Current assets:
Cash and cash equivalents	317	300	323	258
Accounts receivable, net	2,443	2,224
Inventories	468	457
Deferred income taxes
Other	495	451
Total current assets	3,723	3,432
Property and equipment, net	5,855	5,768
Investments of insurance subsidiaries	402	515
Investments in and advances to affiliates	110	88
Goodwill and other intangible assets	4,137	3,842
Deferred loan costs
Other	339	179
Total assets	14,566	13,824
Current liabilities:
Accounts payable	569	565
Accrued salaries	451	482
Other accrued expenses	809	788
Long-term debt due within one year	39	36
Total current liabilities	1,868	1,871
Long-term debt	525	493
Intercompany balances	3,472	3,406
Professional liability risks	959	973
Income taxes and other liabilities	256	220
Total liabilities	7,080	6,963
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	6,269	5,642
Noncontrolling interests	1,217	1,219
Total stockholders' deficit	7,486	6,861
Total liabilities and stockholders' deficit	14,566	13,824
Eliminations [Member]
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventories
Deferred income taxes
Other
Total current assets
Property and equipment, net
Investments of insurance subsidiaries
Investments in and advances to affiliates	(19,784)	(18,481)
Goodwill and other intangible assets
Deferred loan costs
Other
Total assets	(19,784)	(18,481)
Current liabilities:
Accounts payable
Accrued salaries
Other accrued expenses
Long-term debt due within one year
Total current liabilities
Long-term debt
Intercompany balances
Professional liability risks
Income taxes and other liabilities
Total liabilities
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	(19,784)	(18,481)
Noncontrolling interests
Total stockholders' deficit	(19,784)	(18,481)
Total liabilities and stockholders' deficit	$ (19,784)	$ (18,481)

XML

Supplemental Condensed Consolidating Financial Information

9 Months Ended

Sep. 30, 2013

Text Block [Abstract]

Supplemental Condensed Consolidating Financial Information

NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 ³/₄% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).

Our summarized condensed consolidating comprehensive income statements for the quarters and nine months ended September 30, 2013 and 2012, condensed consolidating balance sheets at September 30, 2013 and December 31, 2012 and condensed consolidating statements of cash flows for the nine months ended September 30, 2013 and 2012, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,945		$	4,466		$	—		$	9,411
Provision for doubtful accounts		—			—			560			395			—			955
Revenues		—			—			4,385			4,071			—			8,456
Salaries and benefits		—			—			2,090			1,826			—			3,916
Supplies		—			—			773			684			—			1,457
Other operating expenses		2			(1	)		771			792			—			1,564
Electronic health record incentive income		—			—			(53	)		(22	)		—			(75	)
Equity in earnings of affiliates		(443	)		—			—			(9	)		443			(9	)
Depreciation and amortization		—			—			216			227			—			443
Interest expense		41			549			(104	)		(28	)		—			458
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(183	)		183			—			—
		(400	)		548			3,511			3,653			443			7,755
Income (loss) before income taxes		400			(548	)		874			418			(443	)		701
Provision (benefit) for income taxes		(17	)		(214	)		334			131			—			234
Net income (loss)		417			(334	)		540			287			(443	)		467
Net income attributable to noncontrolling interests		—			—			19			83			—			102
Net income (loss) attributable to HCA Holdings, Inc.	$	417		$	(334	)	$	521		$	204		$	(443	)	$	365
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	417		$	(331	)	$	532		$	242		$	(443	)	$	417

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,672		$	4,221		$	—		$	8,893
Provision for doubtful accounts		—			—			484			347			—			831
Revenues		—			—			4,188			3,874			—			8,062
Salaries and benefits		—			—			1,995			1,786			—			3,781
Supplies		—			—			711			664			—			1,375
Other operating expenses		—			3			761			746			—			1,510
Electronic health record incentive income		—			—			(85	)		(46	)		—			(131	)
Equity in earnings of affiliates		(379	)		—			(1	)		(5	)		379			(6	)
Depreciation and amortization		—			—			205			212			—			417
Interest expense		30			545			(98	)		(31	)		—			446
Gains on sales of facilities		—			—			—			(7	)		—			(7	)
Management fees		—			—			(170	)		170			—			—
		(349	)		548			3,318			3,489			379			7,385
Income (loss) before income taxes		349			(548	)		870			385			(379	)		677
Provision (benefit) for income taxes		(11	)		(208	)		325			116			—			222
Net income (loss)		360			(340	)		545			269			(379	)		455
Net income attributable to noncontrolling interests		—			—			18			77			—			95
Net income (loss) attributable to HCA Holdings, Inc.	$	360		$	(340	)	$	527		$	192		$	(379	)	$	360
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	360		$	(357	)	$	531		$	214		$	(379	)	$	369

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,829		$	13,249		$	—		$	28,078
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Revenues		—			—			13,218			12,128			—			25,346
Salaries and benefits		—			—			6,275			5,406			—			11,681
Supplies		—			—			2,340			2,066			—			4,406
Other operating expenses		4			(1	)		2,260			2,331			—			4,594
Electronic health record incentive income		—			—			(115	)		(51	)		—			(166	)
Equity in earnings of affiliates		(1,303	)		—			(2	)		(27	)		1,303			(29	)
Depreciation and amortization		—			—			636			656			—			1,292
Interest expense		138			1,651			(319	)		(78	)		—			1,392
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(547	)		547			—			—
		(1,161	)		1,667			10,548			10,843			1,303			23,200
Income (loss) before income taxes		1,161			(1,667	)		2,670			1,285			(1,303	)		2,146
Provision (benefit) for income taxes		(54	)		(639	)		1,005			392			—			704
Net income (loss)		1,215			(1,028	)		1,665			893			(1,303	)		1,442
Net income attributable to noncontrolling interests		—			—			48			262			—			310
Net income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(1,028	)	$	1,617		$	631		$	(1,303	)	$	1,132
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(961	)	$	1,637		$	627		$	(1,303	)	$	1,215

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,328		$	12,917		$	—		$	27,245
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Revenues		—			—			12,823			11,756			—			24,579
Salaries and benefits		—			—			5,928			5,296			—			11,224
Supplies		—			—			2,202			2,014			—			4,216
Other operating expenses		—			7			2,241			2,248			—			4,496
Electronic health record incentive income		—			—			(174	)		(82	)		—			(256	)
Equity in earnings of affiliates		(1,348	)		—			(4	)		(22	)		1,348			(26	)
Depreciation and amortization		—			—			614			640			—			1,254
Interest expense		90			1,603			(274	)		(83	)		—			1,336
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(498	)		498			—			—
		(1,258	)		1,610			10,038			10,502			1,348			22,240
Income (loss) before income taxes		1,258			(1,610	)		2,785			1,254			(1,348	)		2,339
Provision (benefit) for income taxes		(33	)		(597	)		1,014			376			—			760
Net income (loss)		1,291			(1,013	)		1,771			878			(1,348	)		1,579
Net income attributable to noncontrolling interests		—			—			51			237			—			288
Net income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,013	)	$	1,720		$	641		$	(1,348	)	$	1,291
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,055	)	$	1,733		$	670		$	(1,348	)	$	1,291

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	167		$	317	$	—		$	484
Accounts receivable, net		—			—			2,481			2,443		—			4,924
Inventories		—			—			667			468		—			1,135
Deferred income taxes		400			—			—			—		—			400
Other		6			—			327			495		—			828
		406			—			3,642			3,723		—			7,771
Property and equipment, net		—			—			7,467			5,855		—			13,322
Investments of insurance subsidiaries		—			—			—			402		—			402
Investments in and advances to affiliates		19,784			—			15			110		(19,784	)		125
Goodwill and other intangible assets		—			—			1,695			4,137		—			5,832
Deferred loan costs		30			220			—			—		—			250
Other		315			—			37			339		—			691
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,012		$	569	$	—		$	1,582
Accrued salaries		—			—			634			451		—			1,085
Other accrued expenses		255			259			441			809		—			1,764
Long-term debt due within one year		—			906			43			39		—			988
		256			1,165			2,130			1,868		—			5,419
Long-term debt		2,525			24,174			165			525		—			27,389
Intercompany balances		25,682			(10,477	)		(18,677	)		3,472		—			—
Professional liability risks		—			—			—			959		—			959
Income taxes and other liabilities		448			327			639			256		—			1,670
		28,911			15,189			(15,743	)		7,080		—			35,437
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,376	)		(14,969	)		28,484			6,269		(19,784	)		(8,376	)
Noncontrolling interests		—			—			115			1,217		—			1,332
		(8,376	)		(14,969	)		28,599			7,486		(19,784	)		(7,044	)
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,215		$	(1,028	)	$	1,665		$	893		$	(1,303	)	$	1,442
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		47			(126	)		(1,848	)		(1,392	)		—			(3,319	)
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Depreciation and amortization		—			—			636			656			—			1,292
Income taxes		158			—			—			—			—			158
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		3			38			—			—			—			41
Share-based compensation		81			—			—			—			—			81
Equity in earnings of affiliates		(1,303	)		—			—			—			1,303			—
Other		—			7			—			(10	)		—			(3	)
Net cash provided by (used in) operating activities		201			(1,092	)		2,084			1,261			—			2,454
Cash flows from investing activities:
Purchase of property and equipment		—			—			(684	)		(663	)		—			(1,347	)
Acquisition of hospitals and health care entities		—			—			—			(463	)		—			(463	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			(6	)		103			—			97
Other		—			—			—			8			—			8
Net cash used in investing activities		—			—			(673	)		(1,001	)		—			(1,674	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			630			—			—			—			630
Repayment of long-term debt		—			(1,243	)		(34	)		(23	)		—			(1,300	)
Distributions to noncontrolling interests		—			—			(34	)		(274	)		—			(308	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(13	)		—			—			—			—			(13	)
Changes in intercompany balances with affiliates, net		(199	)		1,710			(1,559	)		48			—			—
Income tax benefits		70			—			—			—			—			70
Other		(81	)		—			—			6			—			(75	)
Net cash (used in) provided by financing activities		(223	)		1,092			(1,627	)		(243	)		—			(1,001	)
Change in cash and cash equivalents		(22	)		—			(216	)		17			—			(221	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	167		$	317		$	—		$	484

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,291		$	(1,013	)	$	1,771		$	878		$	(1,348	)	$	1,579
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(131	)		(1,475	)		(1,347	)		—			(2,923	)
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Depreciation and amortization		—			—			614			640			—			1,254
Income taxes		250			—			—			—			—			250
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Amortization of deferred loan costs		1			43			—			—			—			44
Share-based compensation		39			—			—			—			—			39
Equity in earnings of affiliates		(1,348	)		—			—			—			1,348			—
Other		—			11			—			(4	)		—			7
Net cash provided by (used in) operating activities		263			(1,090	)		2,418			1,321			—			2,912
Cash flows from investing activities:
Purchase of property and equipment		—			—			(685	)		(583	)		—			(1,268	)
Acquisition of hospitals and health care entities		—			—			(72	)		(95	)		—			(167	)
Disposition of hospitals and health care entities		—			—			1			16			—			17
Change in investments		—			—			(9	)		82			—			73
Other		—			—			(1	)		6			—			5
Net cash used in investing activities		—			—			(766	)		(574	)		—			(1,340	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(875	)		—			—			—			(875	)
Repayment of long-term debt		—			(604	)		(16	)		(69	)		—			(689	)
Distributions to noncontrolling interests		—			—			(46	)		(257	)		—			(303	)
Payment of debt issuance costs		—			(20	)		—			—			—			(20	)
Distributions to stockholders		(983	)		—			—			—			—			(983	)
Changes in intercompany balances with affiliates, net		675			1,239			(1,556	)		(358	)		—			—
Income tax benefits		82			—			—			—			—			82
Other		(37	)		—			—			2			—			(35	)
Net cash (used in) provided by financing activities		(263	)		1,090			(1,618	)		(682	)		—			(1,473	)
Change in cash and cash equivalents		—			—			34			65			—			99
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	149		$	323		$	—		$	472

XML

Contingencies and Legal Claim Costs - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	0 Months Ended	3 Months Ended	12 Months Ended				3 Months Ended
	Oct. 28, 2011 Cases	Dec. 31, 2012	Dec. 31, 2012	Sep. 30, 2013 Hospital	Dec. 31, 2003	Jul. 31, 2012 FLORIDA Hospital	Dec. 31, 2012 Pending Litigation [Member] Health Care Foundation of Greater Kansas City [Member]
Schedule Of Activities Related To Claims Filed [Line Items]
Number of owned and operated hospitals reviewed				95		8
Number of claims filed	3
Capital commitments in connection with purchase of hospitals					$ 450
Legal claim costs		175
Judgment award by the court							162
Period of agreed capital commitments			5 years
Number of year under court-supervisor accounting for expenditures following the purchase			10 years
Plaintiff attorneys fees award							$ 12

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income (loss)	$ 1,442	$ 1,579
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(3,319)	(2,923)
Provision for doubtful accounts	2,732	2,666
Depreciation and amortization	1,292	1,254
Income taxes	158	250
Losses (gains) on sales of facilities	13	(4)
Loss on retirement of debt	17
Amortization of deferred loan costs	41	44
Share-based compensation	81	39
Equity in earnings of affiliates	(29)	(26)
Other	(3)	7
Net cash provided by (used in) operating activities	2,454	2,912
Cash flows from investing activities:
Purchase of property and equipment	(1,347)	(1,268)
Acquisition of hospitals and health care entities	(463)	(167)
Disposition of hospitals and health care entities	31	17
Change in investments	97	73
Other	8	5
Net cash used in investing activities	(1,674)	(1,340)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	630	(875)
Repayment of long-term debt	(1,300)	(689)
Distributions to noncontrolling interests	(308)	(303)
Payment of debt issuance costs	(5)	(20)
Distributions to stockholders	(13)	(983)
Income tax benefits	70	82
Other	(75)	(35)
Net cash (used in) provided by financing activities	(1,001)	(1,473)
Change in cash and cash equivalents	(221)	99
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	484	472
HCA Holdings, Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	1,215	1,291
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	47	30
Provision for doubtful accounts
Depreciation and amortization
Income taxes	158	250
Losses (gains) on sales of facilities
Loss on retirement of debt
Amortization of deferred loan costs	3	1
Share-based compensation	81	39
Equity in earnings of affiliates	(1,303)	(1,348)
Other
Net cash provided by (used in) operating activities	201	263
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt
Distributions to noncontrolling interests
Payment of debt issuance costs
Distributions to stockholders	(13)	(983)
Changes in intercompany balances with affiliates, net	(199)	675
Income tax benefits	70	82
Other	(81)	(37)
Net cash (used in) provided by financing activities	(223)	(263)
Change in cash and cash equivalents	(22)
Cash and cash equivalents at beginning of period	22
Cash and cash equivalents at end of period
HCA Inc. Issuer [Member]
Cash flows from operating activities:
Net income (loss)	(1,028)	(1,013)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(126)	(131)
Provision for doubtful accounts
Depreciation and amortization
Income taxes
Losses (gains) on sales of facilities
Loss on retirement of debt	17
Amortization of deferred loan costs	38	43
Share-based compensation
Equity in earnings of affiliates
Other	7	11
Net cash provided by (used in) operating activities	(1,092)	(1,090)
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving bank credit facilities	630	(875)
Repayment of long-term debt	(1,243)	(604)
Distributions to noncontrolling interests
Payment of debt issuance costs	(5)	(20)
Distributions to stockholders
Changes in intercompany balances with affiliates, net	1,710	1,239
Income tax benefits
Other
Net cash (used in) provided by financing activities	1,092	1,090
Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Subsidiary Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	1,665	1,771
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(1,848)	(1,475)
Provision for doubtful accounts	1,611	1,505
Depreciation and amortization	636	614
Income taxes
Losses (gains) on sales of facilities	20	3
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	(2)	(4)
Other
Net cash provided by (used in) operating activities	2,084	2,418
Cash flows from investing activities:
Purchase of property and equipment	(684)	(685)
Acquisition of hospitals and health care entities		(72)
Disposition of hospitals and health care entities	17	1
Change in investments	(6)	(9)
Other		(1)
Net cash used in investing activities	(673)	(766)
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt	(34)	(16)
Distributions to noncontrolling interests	(34)	(46)
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net	(1,559)	(1,556)
Income tax benefits
Other
Net cash (used in) provided by financing activities	(1,627)	(1,618)
Change in cash and cash equivalents	(216)	34
Cash and cash equivalents at beginning of period	383	115
Cash and cash equivalents at end of period	167	149
Subsidiary Non-Guarantors [Member]
Cash flows from operating activities:
Net income (loss)	893	878
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities	(1,392)	(1,347)
Provision for doubtful accounts	1,121	1,161
Depreciation and amortization	656	640
Income taxes
Losses (gains) on sales of facilities	(7)	(7)
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	(27)	(22)
Other	(10)	(4)
Net cash provided by (used in) operating activities	1,261	1,321
Cash flows from investing activities:
Purchase of property and equipment	(663)	(583)
Acquisition of hospitals and health care entities	(463)	(95)
Disposition of hospitals and health care entities	14	16
Change in investments	103	82
Other	8	6
Net cash used in investing activities	(1,001)	(574)
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt	(23)	(69)
Distributions to noncontrolling interests	(274)	(257)
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net	48	(358)
Income tax benefits
Other	6	2
Net cash (used in) provided by financing activities	(243)	(682)
Change in cash and cash equivalents	17	65
Cash and cash equivalents at beginning of period	300	258
Cash and cash equivalents at end of period	317	323
Eliminations [Member]
Cash flows from operating activities:
Net income (loss)	(1,303)	(1,348)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities
Provision for doubtful accounts
Depreciation and amortization
Income taxes
Losses (gains) on sales of facilities
Loss on retirement of debt
Amortization of deferred loan costs
Share-based compensation
Equity in earnings of affiliates	1,303	1,348
Other
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of hospitals and health care entities
Disposition of hospitals and health care entities
Change in investments
Other
Net cash used in investing activities
Cash flows from financing activities:
Issuance of long-term debt
Net change in revolving bank credit facilities
Repayment of long-term debt
Distributions to noncontrolling interests
Payment of debt issuance costs
Distributions to stockholders
Changes in intercompany balances with affiliates, net
Income tax benefits
Other
Net cash (used in) provided by financing activities
Change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

XML

Financial Instruments - Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) (Pay-Fixed Interest Rate Swaps [Member], USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Maturity Date, 2014 [Member]
Derivative Instruments [Line Items]
Fair Value	$ (6)
Notional Amount	500
Pay-fixed interest rate swaps	Dec. 31, 2014
Maturity Date, 2016 [Member]
Derivative Instruments [Line Items]
Fair Value	(269)
Notional Amount	3,000
Pay-fixed interest rate swaps	Dec. 31, 2016
Maturity Date, 2017 [Member]
Derivative Instruments [Line Items]
Fair Value	(48)
Notional Amount	$ 1,000
Pay-fixed interest rate swaps	Dec. 31, 2017

XML

Capital Structure (Tables)

9 Months Ended

Sep. 30, 2013

Text Block [Abstract]

Schedule of Changes in Stockholders' Deficit and Equity

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			1,132			310			1,442
Other comprehensive income		—		—		—			83			—			—			83
Distributions		—		—		—			—			—			(308	)		(308	)
Share-based benefit plans		4,373		—		71			—			—			—			71
Other		—		—		(3	)		—			1			11			9
Balances at September 30, 2013		447,573	$	4	$	1,821		$	(374	)	$	(9,827	)	$	1,332		$	(7,044	)

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(4	)		—			—			—			(4	)
Defined benefit plans, net of $3 of income taxes		—			—			5			—			5
Change in fair value of derivative instruments, net of $3 of income taxes		—			—			—			6			6
Expense reclassified into operations from other comprehensive income, net of $9 and $36, respectively, income tax benefits		—			—			15			61			76
Balances at September 30, 2013	$	7		$	(1	)	$	(176	)	$	(204	)	$	(374	)

XML

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

A summary of long-term debt at September 30, 2013 and December 31, 2012, including related interest rates at September 30, 2013, follows (dollars in millions):

	September 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,100	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,944		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,693		9,688
Other senior secured debt (effective interest rate of 6.8%)		446		423
First lien debt		18,183		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,194		11,194
Total debt (average life of 6.5 years, rates averaging 6.3%)		28,377		28,930
Less amounts due within one year		988		1,435
	$	27,389	$	27,495

XML

Long-Term Debt - Schedule of Long-Term Debt (Parenthetical) (Detail)	Sep. 30, 2013
Debt Instrument [Line Items]
Total debt average term	6 years 6 months
Total debt average rate	6.30%
Senior Secured Asset-Based Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Effective interest rate	1.70%
Senior Secured Term Loan Facilities [Member]
Debt Instrument [Line Items]
Effective interest rate	5.10%
Senior Secured First Lien Notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.10%
Other Senior Secured Debt [Member]
Debt Instrument [Line Items]
Effective interest rate	6.80%
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Effective interest rate	7.20%

XML

Earnings Per Share - Schedule of Computations of Basic and Diluted Earnings Per Share (Detail) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Earnings Per Share [Abstract]
Net income attributable to HCA Holdings, Inc.	$ 365	$ 360	$ 1,132	$ 1,291
Weighted average common shares outstanding	447,329	440,899	446,125	439,441
Effect of dilutive incremental shares	16,240	18,616	16,926	19,381
Shares used for diluted earnings per share	463,569	459,515	463,051	458,822
Basic earnings per share	$ 0.82	$ 0.82	$ 2.54	$ 2.94
Diluted earnings per share	$ 0.79	$ 0.78	$ 2.44	$ 2.81

XML

Financial Instruments - Schedule of Cross Currency Swap Agreement Not Designated as Hedge (Detail) (Euro - United States Dollar Currency Swap [Member], Maturity Date, November 2013 [Member]) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013 USD ($)	Sep. 30, 2013 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value	$ (4)
Maturity Date	Nov. 30, 2013	Nov. 30, 2013
Notional amount for foreign currency derivatives		€ 241

XML

Capital Structure - Schedule of Changes in Stockholders' Deficit and Equity (Detail) (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Capital Structure [Line Items]
Beginning Balance			$ (8,341)
Net income	467	455	1,442	1,579
Other comprehensive income	52	9	83
Distributions			(308)
Share-based benefit plans			71
Other			9
Ending Balance	(7,044)		(7,044)
Common Stock [Member]
Capital Structure [Line Items]
Beginning Balance			4
Ending Balance	4		4
Beginning Balance, Shares			443,200
Share-based benefit plans, Shares			4,373
Ending Balance, Shares	447,573		447,573
Capital in Excess of Par Value [Member]
Capital Structure [Line Items]
Beginning Balance			1,753
Share-based benefit plans			71
Other			(3)
Ending Balance	1,821		1,821
Accumulated Other Comprehensive Loss [Member]
Capital Structure [Line Items]
Beginning Balance			(457)
Other comprehensive income			83
Ending Balance	(374)		(374)
Retained Deficit [Member]
Capital Structure [Line Items]
Beginning Balance			(10,960)
Net income			1,132
Other			1
Ending Balance	(9,827)		(9,827)
Equity Attributable to Noncontrolling Interests [Member]
Capital Structure [Line Items]
Beginning Balance			1,319
Net income			310
Distributions			(308)
Other			11
Ending Balance	$ 1,332		$ 1,332

XML

Interim Condensed Consolidated Financial Statements - Schedule of Revenues from Third Party Payers and Uninsured (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Revenues [Line Items]
Revenues from third party payers	$ 8,351	$ 8,102	$ 25,310	$ 24,837
Uninsured	717	576	1,809	1,757
Other	343	215	959	651
Revenues before provision for doubtful accounts	9,411	8,893	28,078	27,245
Provision for doubtful accounts	(955)	(831)	(2,732)	(2,666)
Revenues	8,456	8,062	25,346	24,579
Revenues from third party payers, ratio	98.70%	100.40%	99.80%	101.00%
Uninsured Ratio	8.50%	7.10%	7.10%	7.10%
Other Ratio	4.10%	2.70%	3.80%	2.70%
Revenues before provision for doubtful accounts, ratio	111.30%	110.20%	110.70%	110.80%
Provision for doubtful accounts Ratio	(11.30%)	(10.20%)	(10.70%)	(10.80%)
Revenues ratio from third party payers	100.00%	100.00%	100.00%	100.00%
Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	1,847	1,949	5,961	6,251
Revenues from third party payers, ratio	21.80%	24.20%	23.50%	25.40%
Managed Medicare [Member]
Revenues [Line Items]
Revenues from third party payers	794	720	2,441	2,199
Revenues from third party payers, ratio	9.40%	8.90%	9.60%	8.90%
Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	401	378	1,098	1,188
Revenues from third party payers, ratio	4.70%	4.70%	4.30%	4.80%
Managed Medicaid [Member]
Revenues [Line Items]
Revenues from third party payers	386	380	1,165	1,080
Revenues from third party payers, ratio	4.60%	4.70%	4.60%	4.40%
Managed Care and Other Insurers [Member]
Revenues [Line Items]
Revenues from third party payers	4,636	4,422	13,777	13,340
Revenues from third party payers, ratio	54.80%	54.80%	54.40%	54.30%
International (Managed Care and Other Insurers) [Member]
Revenues [Line Items]
Revenues from third party payers	$ 287	$ 253	$ 868	$ 779
Revenues from third party payers, ratio	3.40%	3.10%	3.40%	3.20%

XML

Assets and Liabilities Measured at Fair Value - Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Fair Value Disclosures [Abstract]
Asset, Beginning Balance	$ 70
Unrealized gains included in other comprehensive income	6
Settlements	(43)
Asset, Ending Balance	$ 33

XML

Assets and Liabilities Measured at Fair Value (Tables)

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	September 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	393		$	—		$	393		$	—
Auction rate securities		32			—			—			32
Asset-backed securities		13			—			13			—
Money market funds		24			24			—			—
		462			24			406			32
Equity securities		3			2			—			1
Investments of insurance subsidiaries		465			26			406			33
Less amounts classified as current assets		(63	)		(24	)		(39	)		—
	$	402		$	2		$	367		$	33
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	4		$	—		$	4		$	—
Interest rate swaps (Income taxes and other liabilities)		323			—			323			—

Derivative Financial Instruments (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

Schedule Related to Auction Rate and Equity Securities Investments of Insurance Subsidiaries at Fair Value

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the nine months ended September 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$70
Unrealized gains included in other comprehensive income		6
Settlements		(43	)
Asset balances at September 30, 2013	$	33

XML

Condensed Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 1,442	$ 1,579
Adjustments to reconcile net income to net cash provided by operating activities:
Changes in operating assets and liabilities	(3,319)	(2,923)
Provision for doubtful accounts	2,732	2,666
Depreciation and amortization	1,292	1,254
Income taxes	158	250
Losses (gains) on sales of facilities	13	(4)
Loss on retirement of debt	17
Amortization of deferred loan costs	41	44
Share-based compensation	81	39
Other	(3)	7
Net cash provided by (used in) operating activities	2,454	2,912
Cash flows from investing activities:
Purchase of property and equipment	(1,347)	(1,268)
Acquisition of hospitals and health care entities	(463)	(167)
Disposition of hospitals and health care entities	31	17
Change in investments	97	73
Other	8	5
Net cash used in investing activities	(1,674)	(1,340)
Cash flows from financing activities:
Issuance of long-term debt		1,350
Net change in revolving credit facilities	630	(875)
Repayment of long-term debt	(1,300)	(689)
Distributions to noncontrolling interests	(308)	(303)
Payment of debt issuance costs	(5)	(20)
Distributions to stockholders	(13)	(983)
Income tax benefits	70	82
Other	(75)	(35)
Net cash (used in) provided by financing activities	(1,001)	(1,473)
Change in cash and cash equivalents	(221)	99
Cash and cash equivalents at beginning of period	705	373
Cash and cash equivalents at end of period	484	472
Interest payments	1,464	1,404
Income tax payments, net	$ 476	$ 428

XML

Acquisitions and Dispositions

9 Months Ended

Sep. 30, 2013

Business Combinations [Abstract]

Acquisitions and Dispositions

NOTE 2 — ACQUISITIONS AND DISPOSITIONS

During the nine months ended September 30, 2013, we paid $278 million and recorded goodwill and identifiable intangible assets of $180 million and $113 million, respectively, related to the acquisition of The Outsource Group, which was acquired by our Parallon Business Solutions affiliate and is included in the Corporate and other Group. During the nine months ended September 30, 2013, we also paid $39 million to acquire nonhospital health care entities and $146 million related to the acquisition of three hospitals which became effective October 1, 2013. During the nine months ended September 30, 2012, we paid $58 million, assumed liabilities of $33 million and recorded goodwill of $53 million related to the acquisition of a hospital facility in the American Group, and we paid $109 million to acquire nonhospital health care entities.

During the nine months ended September 30, 2013, we received proceeds of $31 million and recognized a net pretax loss of $13 million related to the sale of a hospital facility and other real estate investments. During the nine months ended September 30, 2012, we received proceeds of $17 million and recognized a net pretax gain of $4 million related to sales of real estate investments.

XML

Investments of Insurance Subsidiaries

9 Months Ended

Sep. 30, 2013

Investments Debt And Equity Securities [Abstract]

Investments of Insurance Subsidiaries

NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of our insurance subsidiaries’ investments at September 30, 2013 and December 31, 2012 follows (dollars in millions):

	September 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	383	$	12	$	(2	)	$	393
Auction rate securities		32		—		—			32
Asset-backed securities		13		—		—			13
Money market funds		24		—		—			24
		452		12		(2	)		462
Equity securities		2		1		—			3
	$	454	$	13	$	(2	)		465
Amounts classified as current assets									(63	)
Investment carrying value								$	402

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

At September 30, 2013 and December 31, 2012, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income. At September 30, 2013 and December 31, 2012, $1 million and $9 million, respectively, of our money market fund investments were subject to restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at September 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	41	$	41
Due after one year through five years		176		182
Due after five years through ten years		108		111
Due after ten years		82		83
		407		417
Auction rate securities		32		32
Asset-backed securities		13		13
	$	452	$	462

The average expected maturity of the investments in debt securities at September 30, 2013 was 4.0 years, compared to the average scheduled maturity of 7.1 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to the scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. At September 30, 2013, the average expected maturities for our auction rate and asset-backed securities were 1.4 years and 3.9 years, respectively, compared to average scheduled maturities of 22.1 years and 22.7 years, respectively.

XML

Income Taxes

9 Months Ended

Sep. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

NOTE 3 — INCOME TAXES

During the nine months ended September 30, 2013, we finalized settlements with the IRS resolving all outstanding issues for HCA Inc.’s 2007, 2008 and 2009 tax years. We expect the IRS Examination Division will begin an audit of HCA Holdings, Inc.’s 2011 federal income tax return in 2014.

Our liability for unrecognized tax benefits was $417 million, including accrued interest of $26 million, as of September 30, 2013 ($426 million and $14 million, respectively, as of December 31, 2012). Unrecognized tax benefits of $151 million ($125 million as of December 31, 2012) would affect the effective rate, if recognized. The provision for income taxes reflects $7 million and $1 million ($4 million and none, respectively, net of tax) of interest expense related to taxing authority examinations for the quarters ended September 30, 2013 and 2012, respectively, and $8 million and $20 million ($5 million and $13 million, respectively, net of tax) of reductions in interest expense related to taxing authority examinations for the nine months ended September 30, 2013 and 2012, respectively.

Depending on the completion of examinations by federal, state or international taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

XML

Financial Instruments - Effect of Interest Rate and Cross Currency Swaps on Results of Operations (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Cross Currency Swap (Income Taxes and Other Liabilities) [Member] | Other Operating Expenses [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Recognized in Operations on Derivatives	$ 9
Interest Rate Swaps [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain Recognized in OCI on Derivatives, Net of Tax	6
Interest Rate Swaps [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Loss Reclassified from Accumulated OCI into Operations	$ 97

XML

Segment and Geographic Information (Tables)

9 Months Ended

Sep. 30, 2013

Segment Reporting [Abstract]

Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA, Depreciation and Amortization and Assets

The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter						Nine Months
	2013			2012			2013			2012
Revenues:
National Group	$	3,930		$	3,755		$	11,875		$	11,553
American Group		4,082			3,982			12,181			12,033
Corporate and other		444			325			1,290			993
	$	8,456		$	8,062		$	25,346		$	24,579
Equity in earnings of affiliates:
National Group	$	(3	)	$	—		$	(8	)	$	(7	)
American Group		(6	)		(6	)		(19	)		(20	)
Corporate and other		—			—			(2	)		1
	$	(9	)	$	(6	)	$	(29	)	$	(26	)
Adjusted segment EBITDA:
National Group	$	805		$	768		$	2,440		$	2,478
American Group		910			843			2,654			2,657
Corporate and other		(112	)		(78	)		(234	)		(210	)
	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization:
National Group	$	181		$	171		$	532		$	520
American Group		206			207			610			612
Corporate and other		56			39			150			122
	$	443		$	417		$	1,292		$	1,254
Adjusted segment EBITDA	$	1,603		$	1,533		$	4,860		$	4,925
Depreciation and amortization		443			417			1,292			1,254
Interest expense		458			446			1,392			1,336
Losses (gains) on sales of facilities		1			(7	)		13			(4	)
Loss on retirement of debt		—			—			17			—
Income before income taxes	$	701		$	677		$	2,146		$	2,339

XML

Acquisitions and Dispositions - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Hospitals [Member]
Business Acquisition [Line Items]
Cash paid for acquisition		$ 58
Goodwill recorded on acquisition		53
Payment to acquire hospitals	146
Liability assumed on acquisition		33
Pretax gain on sales of business	13
Proceeds from sale of business	31
Real Estate [Member]
Business Acquisition [Line Items]
Pretax gain on sales of business		4
Proceeds from sale of business		17
Outsource Group (Member)
Business Acquisition [Line Items]
Cash paid for acquisition	278
Goodwill recorded on acquisition	180
Payment to acquire intangible assets	113
Other Healthcare Entity [Member]
Business Acquisition [Line Items]
Cash paid for acquisition	$ 39	$ 109
Number of Hospital acquired	3

XML

Investments of Insurance Subsidiaries - Schedule of Maturities of Investments (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
Due in one year or less, Amortized Cost	$ 41
Due after one year through five years, Amortized Cost	176
Due after five years through ten years, Amortized Cost	108
Due after ten years, Amortized Cost	82
Amortized Cost, Total	407
Amortized Cost	452
Due in one year or less, Fair Value	41
Fair Value	465	570
Due after one year through five years, Fair Value	182
Due after five years through ten years, Fair Value	111
Due after ten years, Fair Value	83
Fair Value, Total	417
Fair Value	462
Auction Rate Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	32
Fair Value	32
Asset-Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	13
Fair Value	$ 13

XML

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Comprehensive Income Statement (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended	3 Months Ended		9 Months Ended
	Mar. 31, 2013	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts		$ 9,411	$ 8,893	$ 28,078	$ 27,245
Provision for doubtful accounts		955	831	2,732	2,666
Revenues		8,456	8,062	25,346	24,579
Salaries and benefits		3,916	3,781	11,681	11,224
Supplies		1,457	1,375	4,406	4,216
Other operating expenses		1,564	1,510	4,594	4,496
Electronic health record incentive income		(75)	(131)	(166)	(256)
Equity in earnings of affiliates		(9)	(6)	(29)	(26)
Depreciation and amortization		443	417	1,292	1,254
Interest expense		458	446	1,392	1,336
Losses (gains) on sales of facilities		1	(7)	13	(4)
Loss on retirement of debt	17			17
Management fees
Total expenses including equity in earnings of a affiliates		7,755	7,385	23,200	22,240
Income (loss) before income taxes		701	677	2,146	2,339
Provision (benefit) for income taxes		234	222	704	760
Net income (loss)		467	455	1,442	1,579
Net income attributable to noncontrolling interests		102	95	310	288
Net income (loss) attributable to HCA Holdings, Inc.		365	360	1,132	1,291
Comprehensive income (loss) attributable to HCA Holdings, Inc.		417	369	1,215	1,291
HCA Holdings, Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses		2		4
Electronic health record incentive income
Equity in earnings of affiliates		(443)	(379)	(1,303)	(1,348)
Depreciation and amortization
Interest expense		41	30	138	90
Losses (gains) on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates		(400)	(349)	(1,161)	(1,258)
Income (loss) before income taxes		400	349	1,161	1,258
Provision (benefit) for income taxes		(17)	(11)	(54)	(33)
Net income (loss)		417	360	1,215	1,291
Net income attributable to noncontrolling interests
Net income (loss) attributable to HCA Holdings, Inc.		417	360	1,215	1,291
Comprehensive income (loss) attributable to HCA Holdings, Inc.		417	360	1,215	1,291
HCA Inc. Issuer [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses		(1)	3	(1)	7
Electronic health record incentive income
Equity in earnings of affiliates
Depreciation and amortization
Interest expense		549	545	1,651	1,603
Losses (gains) on sales of facilities
Loss on retirement of debt				17
Management fees
Total expenses including equity in earnings of a affiliates		548	548	1,667	1,610
Income (loss) before income taxes		(548)	(548)	(1,667)	(1,610)
Provision (benefit) for income taxes		(214)	(208)	(639)	(597)
Net income (loss)		(334)	(340)	(1,028)	(1,013)
Net income attributable to noncontrolling interests
Net income (loss) attributable to HCA Holdings, Inc.		(334)	(340)	(1,028)	(1,013)
Comprehensive income (loss) attributable to HCA Holdings, Inc.		(331)	(357)	(961)	(1,055)
Subsidiary Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts		4,945	4,672	14,829	14,328
Provision for doubtful accounts		560	484	1,611	1,505
Revenues		4,385	4,188	13,218	12,823
Salaries and benefits		2,090	1,995	6,275	5,928
Supplies		773	711	2,340	2,202
Other operating expenses		771	761	2,260	2,241
Electronic health record incentive income		(53)	(85)	(115)	(174)
Equity in earnings of affiliates			(1)	(2)	(4)
Depreciation and amortization		216	205	636	614
Interest expense		(104)	(98)	(319)	(274)
Losses (gains) on sales of facilities		1		20	3
Loss on retirement of debt
Management fees		(183)	(170)	(547)	(498)
Total expenses including equity in earnings of a affiliates		3,511	3,318	10,548	10,038
Income (loss) before income taxes		874	870	2,670	2,785
Provision (benefit) for income taxes		334	325	1,005	1,014
Net income (loss)		540	545	1,665	1,771
Net income attributable to noncontrolling interests		19	18	48	51
Net income (loss) attributable to HCA Holdings, Inc.		521	527	1,617	1,720
Comprehensive income (loss) attributable to HCA Holdings, Inc.		532	531	1,637	1,733
Subsidiary Non-Guarantors [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts		4,466	4,221	13,249	12,917
Provision for doubtful accounts		395	347	1,121	1,161
Revenues		4,071	3,874	12,128	11,756
Salaries and benefits		1,826	1,786	5,406	5,296
Supplies		684	664	2,066	2,014
Other operating expenses		792	746	2,331	2,248
Electronic health record incentive income		(22)	(46)	(51)	(82)
Equity in earnings of affiliates		(9)	(5)	(27)	(22)
Depreciation and amortization		227	212	656	640
Interest expense		(28)	(31)	(78)	(83)
Losses (gains) on sales of facilities			(7)	(7)	(7)
Loss on retirement of debt
Management fees		183	170	547	498
Total expenses including equity in earnings of a affiliates		3,653	3,489	10,843	10,502
Income (loss) before income taxes		418	385	1,285	1,254
Provision (benefit) for income taxes		131	116	392	376
Net income (loss)		287	269	893	878
Net income attributable to noncontrolling interests		83	77	262	237
Net income (loss) attributable to HCA Holdings, Inc.		204	192	631	641
Comprehensive income (loss) attributable to HCA Holdings, Inc.		242	214	627	670
Eliminations [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Revenues before provision for doubtful accounts
Provision for doubtful accounts
Revenues
Salaries and benefits
Supplies
Other operating expenses
Electronic health record incentive income
Equity in earnings of affiliates		443	379	1,303	1,348
Depreciation and amortization
Interest expense
Losses (gains) on sales of facilities
Loss on retirement of debt
Management fees
Total expenses including equity in earnings of a affiliates		443	379	1,303	1,348
Income (loss) before income taxes		(443)	(379)	(1,303)	(1,348)
Provision (benefit) for income taxes
Net income (loss)		(443)	(379)	(1,303)	(1,348)
Net income attributable to noncontrolling interests
Net income (loss) attributable to HCA Holdings, Inc.		(443)	(379)	(1,303)	(1,348)
Comprehensive income (loss) attributable to HCA Holdings, Inc.		$ (443)	$ (379)	$ (1,303)	$ (1,348)

XML

Capital Structure - Components of Accumulated Other Comprehensive Loss (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]
Unrealized gains on available-for-sale securities, beginning balance	$ 11
Unrealized losses on available-for-sale securities, net of income taxes	(4)
Unrealized gains on available-for-sale securities, ending balance	7
Foreign currency translation adjustments, beginning balance	(1)
Foreign currency translation adjustments
Foreign currency translation adjustments, ending balance	(1)
Defined benefit plans, beginning balance	(196)
Defined benefit plans	5
Expense reclassified into operations from other comprehensive income, net of $9 and $36, respectively, income tax benefits	15
Balances at September 30, 2013	(176)
Change in fair value of derivative instruments, beginning balance	(271)
Change in fair value of derivative instruments	6
Change in fair value of derivative instruments, expense reclassified into operations from other comprehensive income	61
Change in fair value of derivative instruments, ending balance	(204)
Accumulated other comprehensive income, net of tax, beginning balance	(457)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit	(4)
Defined benefit plans, net of $3 of income taxes	5
Change in fair value of derivative instruments, net of $3 of income taxes	6
Expense reclassified into operations from other comprehensive income, Total	76
Accumulated other comprehensive income, net of tax, Ending balance	$ (374)

XML

Long-Term Debt - Schedule of Long-Term Debt (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]
First lien debt	$ 18,183	$ 17,539
Total debt (average life of 6.5 years, rates averaging 6.3%)	28,377	28,930
Less amounts due within one year	988	1,435
Long-term debt	27,389	27,495
Senior Secured Asset-Based Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit	2,100	1,470
Senior Secured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Long-term line of credit
Senior Secured Term Loan Facilities [Member]
Debt Instrument [Line Items]
Term loans	5,944	5,958
Senior Secured First Lien Notes [Member]
Debt Instrument [Line Items]
Senior secured first lien notes	9,693	9,688
Other Senior Secured Debt [Member]
Debt Instrument [Line Items]
Other senior secured debt (effective interest rate of 6.8%)	446	423
Senior Secured Second Lien Notes [Member]
Debt Instrument [Line Items]
Senior secured second lien notes		197
Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes	$ 10,194	$ 11,194

XML

Condensed Consolidated Comprehensive Income Statements (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 467	$ 455	$ 1,442	$ 1,579
Other comprehensive income (loss) before taxes:
Foreign currency translation	60	30		37
Unrealized (losses) gains on available-for-sale securities	1	3	(7)	8
Defined benefit plans	8		8
Pension costs included in salaries and benefits	9	7	24	21
Total defined benefit plans	17	7	32	21
Change in fair value of derivative financial instruments	(31)	(56)	9	(158)
Interest costs included in interest expense	33	30	97	90
Total change in fair value of derivative financial instruments	2	(26)	106	(68)
Other comprehensive income (loss) before taxes	80	14	131	(2)
Income taxes (benefits) related to other comprehensive income items	28	5	48	(2)
Other comprehensive income	52	9	83
Comprehensive income	519	464	1,525	1,579
Comprehensive income attributable to noncontrolling interests	102	95	310	288
Comprehensive income attributable to HCA Holdings, Inc.	$ 417	$ 369	$ 1,215	$ 1,291

XML

Long-Term Debt

9 Months Ended

Sep. 30, 2013

Debt Disclosure [Abstract]

Long-Term Debt

NOTE 8 — LONG-TERM DEBT

A summary of long-term debt at September 30, 2013 and December 31, 2012, including related interest rates at September 30, 2013, follows (dollars in millions):

	September 30, 2013		December 31, 2012
Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,100	$	1,470
Senior secured revolving credit facility		—		—
Senior secured term loan facilities (effective interest rate of 5.1%)		5,944		5,958
Senior secured first lien notes (effective interest rate of 7.1%)		9,693		9,688
Other senior secured debt (effective interest rate of 6.8%)		446		423
First lien debt		18,183		17,539
Senior secured second lien notes		—		197
Senior unsecured notes (effective interest rate of 7.2%)		10,194		11,194
Total debt (average life of 6.5 years, rates averaging 6.3%)		28,377		28,930
Less amounts due within one year		988		1,435
	$	27,389	$	27,495

2013 Activity

During March 2013, we redeemed all $201 million aggregate principal amount of our 9 ⁷/₈% senior secured second lien notes due 2017, at a redemption price of 104.938% of the principal amount. The pretax loss on retirement of debt related to this redemption was $17 million.

XML

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Millions, except Share data, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Allowance for Accounts receivable	$ 5,105	$ 4,846
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares outstanding	447,573,400	443,200,200

XML

Subsequent Event - Additional Information (Detail) (Subsequent Event [Member], USD $) In Millions, except Share data, unless otherwise specified	0 Months Ended
	Nov. 02, 2013
Subsequent Event [Member]
Subsequent Event [Line Items]
Underwritten secondary offering	30,000,000
Company repurchased additional shares amount	$ 500
Company repurchased additional shares	10,656,400
Repurchase price per share	$ 46.92

XML

Condensed Consolidated Income Statements (USD $) In Millions, except Share data in Thousands, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Revenues before provision for doubtful accounts	$ 9,411	$ 8,893	$ 28,078	$ 27,245
Provision for doubtful accounts	955	831	2,732	2,666
Revenues	8,456	8,062	25,346	24,579
Salaries and benefits	3,916	3,781	11,681	11,224
Supplies	1,457	1,375	4,406	4,216
Other operating expenses	1,564	1,510	4,594	4,496
Electronic health record incentive income	(75)	(131)	(166)	(256)
Equity in earnings of affiliates	(9)	(6)	(29)	(26)
Depreciation and amortization	443	417	1,292	1,254
Interest expense	458	446	1,392	1,336
Losses (gains) on sales of facilities	1	(7)	13	(4)
Loss on retirement of debt			17
Total expenses including equity in earnings of a affiliates	7,755	7,385	23,200	22,240
Income before income taxes	701	677	2,146	2,339
Provision for income taxes	234	222	704	760
Net income	467	455	1,442	1,579
Net income attributable to noncontrolling interests	102	95	310	288
Net income attributable to HCA Holdings, Inc.	$ 365	$ 360	$ 1,132	$ 1,291
Per share data:
Basic earnings per share	$ 0.82	$ 0.82	$ 2.54	$ 2.94
Diluted earnings per share	$ 0.79	$ 0.78	$ 2.44	$ 2.81
Cash dividends declared per share				$ 2.00
Shares used in earnings per share calculations (in thousands):
Basic	447,329	440,899	446,125	439,441
Diluted	463,569	459,515	463,051	458,822

XML

Capital Structure - Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Equity [Abstract]
Defined benefit plans, income taxes	$ 3
Change in fair value of derivative instruments, (income)expense reclassified into other comprehensive income, Tax Portion	36
Unrealized losses on available-for-Sale Securities, Tax portion	3
Defined benefit plans, income taxes	3
Change in fair value of derivative instruments, income tax benefit	3
Defined Benefit Plan, (Income) expense reclassified into operations from other comprehensive income, Tax portion	9
Change in fair value of derivative instruments,(income)expense reclassified into other comprehensive income, Tax Portion	$ 36

XML

Supplemental Condensed Consolidating Financial Information (Tables)

9 Months Ended

Sep. 30, 2013

Text Block [Abstract]

Schedule of Condensed Consolidating Comprehensive Income Statement

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,945		$	4,466		$	—		$	9,411
Provision for doubtful accounts		—			—			560			395			—			955
Revenues		—			—			4,385			4,071			—			8,456
Salaries and benefits		—			—			2,090			1,826			—			3,916
Supplies		—			—			773			684			—			1,457
Other operating expenses		2			(1	)		771			792			—			1,564
Electronic health record incentive income		—			—			(53	)		(22	)		—			(75	)
Equity in earnings of affiliates		(443	)		—			—			(9	)		443			(9	)
Depreciation and amortization		—			—			216			227			—			443
Interest expense		41			549			(104	)		(28	)		—			458
Losses on sales of facilities		—			—			1			—			—			1
Management fees		—			—			(183	)		183			—			—
		(400	)		548			3,511			3,653			443			7,755
Income (loss) before income taxes		400			(548	)		874			418			(443	)		701
Provision (benefit) for income taxes		(17	)		(214	)		334			131			—			234
Net income (loss)		417			(334	)		540			287			(443	)		467
Net income attributable to noncontrolling interests		—			—			19			83			—			102
Net income (loss) attributable to HCA Holdings, Inc.	$	417		$	(334	)	$	521		$	204		$	(443	)	$	365
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	417		$	(331	)	$	532		$	242		$	(443	)	$	417

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE QUARTER ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	4,672		$	4,221		$	—		$	8,893
Provision for doubtful accounts		—			—			484			347			—			831
Revenues		—			—			4,188			3,874			—			8,062
Salaries and benefits		—			—			1,995			1,786			—			3,781
Supplies		—			—			711			664			—			1,375
Other operating expenses		—			3			761			746			—			1,510
Electronic health record incentive income		—			—			(85	)		(46	)		—			(131	)
Equity in earnings of affiliates		(379	)		—			(1	)		(5	)		379			(6	)
Depreciation and amortization		—			—			205			212			—			417
Interest expense		30			545			(98	)		(31	)		—			446
Gains on sales of facilities		—			—			—			(7	)		—			(7	)
Management fees		—			—			(170	)		170			—			—
		(349	)		548			3,318			3,489			379			7,385
Income (loss) before income taxes		349			(548	)		870			385			(379	)		677
Provision (benefit) for income taxes		(11	)		(208	)		325			116			—			222
Net income (loss)		360			(340	)		545			269			(379	)		455
Net income attributable to noncontrolling interests		—			—			18			77			—			95
Net income (loss) attributable to HCA Holdings, Inc.	$	360		$	(340	)	$	527		$	192		$	(379	)	$	360
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	360		$	(357	)	$	531		$	214		$	(379	)	$	369

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,829		$	13,249		$	—		$	28,078
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Revenues		—			—			13,218			12,128			—			25,346
Salaries and benefits		—			—			6,275			5,406			—			11,681
Supplies		—			—			2,340			2,066			—			4,406
Other operating expenses		4			(1	)		2,260			2,331			—			4,594
Electronic health record incentive income		—			—			(115	)		(51	)		—			(166	)
Equity in earnings of affiliates		(1,303	)		—			(2	)		(27	)		1,303			(29	)
Depreciation and amortization		—			—			636			656			—			1,292
Interest expense		138			1,651			(319	)		(78	)		—			1,392
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(547	)		547			—			—
		(1,161	)		1,667			10,548			10,843			1,303			23,200
Income (loss) before income taxes		1,161			(1,667	)		2,670			1,285			(1,303	)		2,146
Provision (benefit) for income taxes		(54	)		(639	)		1,005			392			—			704
Net income (loss)		1,215			(1,028	)		1,665			893			(1,303	)		1,442
Net income attributable to noncontrolling interests		—			—			48			262			—			310
Net income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(1,028	)	$	1,617		$	631		$	(1,303	)	$	1,132
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,215		$	(961	)	$	1,637		$	627		$	(1,303	)	$	1,215

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Revenues before provision for doubtful accounts	$	—		$	—		$	14,328		$	12,917		$	—		$	27,245
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Revenues		—			—			12,823			11,756			—			24,579
Salaries and benefits		—			—			5,928			5,296			—			11,224
Supplies		—			—			2,202			2,014			—			4,216
Other operating expenses		—			7			2,241			2,248			—			4,496
Electronic health record incentive income		—			—			(174	)		(82	)		—			(256	)
Equity in earnings of affiliates		(1,348	)		—			(4	)		(22	)		1,348			(26	)
Depreciation and amortization		—			—			614			640			—			1,254
Interest expense		90			1,603			(274	)		(83	)		—			1,336
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Management fees		—			—			(498	)		498			—			—
		(1,258	)		1,610			10,038			10,502			1,348			22,240
Income (loss) before income taxes		1,258			(1,610	)		2,785			1,254			(1,348	)		2,339
Provision (benefit) for income taxes		(33	)		(597	)		1,014			376			—			760
Net income (loss)		1,291			(1,013	)		1,771			878			(1,348	)		1,579
Net income attributable to noncontrolling interests		—			—			51			237			—			288
Net income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,013	)	$	1,720		$	641		$	(1,348	)	$	1,291
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	1,291		$	(1,055	)	$	1,733		$	670		$	(1,348	)	$	1,291

Schedule of Condensed Consolidating Balance Sheet

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	167		$	317	$	—		$	484
Accounts receivable, net		—			—			2,481			2,443		—			4,924
Inventories		—			—			667			468		—			1,135
Deferred income taxes		400			—			—			—		—			400
Other		6			—			327			495		—			828
		406			—			3,642			3,723		—			7,771
Property and equipment, net		—			—			7,467			5,855		—			13,322
Investments of insurance subsidiaries		—			—			—			402		—			402
Investments in and advances to affiliates		19,784			—			15			110		(19,784	)		125
Goodwill and other intangible assets		—			—			1,695			4,137		—			5,832
Deferred loan costs		30			220			—			—		—			250
Other		315			—			37			339		—			691
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,012		$	569	$	—		$	1,582
Accrued salaries		—			—			634			451		—			1,085
Other accrued expenses		255			259			441			809		—			1,764
Long-term debt due within one year		—			906			43			39		—			988
		256			1,165			2,130			1,868		—			5,419
Long-term debt		2,525			24,174			165			525		—			27,389
Intercompany balances		25,682			(10,477	)		(18,677	)		3,472		—			—
Professional liability risks		—			—			—			959		—			959
Income taxes and other liabilities		448			327			639			256		—			1,670
		28,911			15,189			(15,743	)		7,080		—			35,437
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,376	)		(14,969	)		28,484			6,269		(19,784	)		(8,376	)
Noncontrolling interests		—			—			115			1,217		—			1,332
		(8,376	)		(14,969	)		28,599			7,486		(19,784	)		(7,044	)
	$	20,535		$	220		$	12,856		$	14,566	$	(19,784	)	$	28,393

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors		Eliminations			Condensed Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	22		$	—		$	383		$	300	$	—		$	705
Accounts receivable, net		—			—			2,448			2,224		—			4,672
Inventories		—			—			629			457		—			1,086
Deferred income taxes		385			—			—			—		—			385
Other		122			—			342			451		—			915
		529			—			3,802			3,432		—			7,763
Property and equipment, net		—			—			7,417			5,768		—			13,185
Investments of insurance subsidiaries		—			—			—			515		—			515
Investments in and advances to affiliates		18,481			—			16			88		(18,481	)		104
Goodwill and other intangible assets		—			—			1,697			3,842		—			5,539
Deferred loan costs		32			258			—			—		—			290
Other		469			—			31			179		—			679
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	—		$	—		$	1,203		$	565	$	—		$	1,768
Accrued salaries		—			—			638			482		—			1,120
Other accrued expenses		30			567			464			788		—			1,849
Long-term debt due within one year		—			1,360			39			36		—			1,435
		30			1,927			2,344			1,871		—			6,172
Long-term debt		2,525			24,304			173			493		—			27,495
Intercompany balances		26,131			(12,407	)		(17,130	)		3,406		—			—
Professional liability risks		—			—			—			973		—			973
Income taxes and other liabilities		485			442			629			220		—			1,776
		29,171			14,266			(13,984	)		6,963		—			36,416
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(9,660	)		(14,008	)		26,847			5,642		(18,481	)		(9,660	)
Noncontrolling interests		—			—			100			1,219		—			1,319
		(9,660	)		(14,008	)		26,947			6,861		(18,481	)		(8,341	)
	$	19,511		$	258		$	12,963		$	13,824	$	(18,481	)	$	28,075

Schedule of Condensed Consolidating Statement of Cash Flows

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2013

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,215		$	(1,028	)	$	1,665		$	893		$	(1,303	)	$	1,442
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		47			(126	)		(1,848	)		(1,392	)		—			(3,319	)
Provision for doubtful accounts		—			—			1,611			1,121			—			2,732
Depreciation and amortization		—			—			636			656			—			1,292
Income taxes		158			—			—			—			—			158
Losses (gains) on sales of facilities		—			—			20			(7	)		—			13
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		3			38			—			—			—			41
Share-based compensation		81			—			—			—			—			81
Equity in earnings of affiliates		(1,303	)		—			—			—			1,303			—
Other		—			7			—			(10	)		—			(3	)
Net cash provided by (used in) operating activities		201			(1,092	)		2,084			1,261			—			2,454
Cash flows from investing activities:
Purchase of property and equipment		—			—			(684	)		(663	)		—			(1,347	)
Acquisition of hospitals and health care entities		—			—			—			(463	)		—			(463	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			(6	)		103			—			97
Other		—			—			—			8			—			8
Net cash used in investing activities		—			—			(673	)		(1,001	)		—			(1,674	)
Cash flows from financing activities:
Net change in revolving bank credit facilities		—			630			—			—			—			630
Repayment of long-term debt		—			(1,243	)		(34	)		(23	)		—			(1,300	)
Distributions to noncontrolling interests		—			—			(34	)		(274	)		—			(308	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(13	)		—			—			—			—			(13	)
Changes in intercompany balances with affiliates, net		(199	)		1,710			(1,559	)		48			—			—
Income tax benefits		70			—			—			—			—			70
Other		(81	)		—			—			6			—			(75	)
Net cash (used in) provided by financing activities		(223	)		1,092			(1,627	)		(243	)		—			(1,001	)
Change in cash and cash equivalents		(22	)		—			(216	)		17			—			(221	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	167		$	317		$	—		$	484

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2012

(Dollars in millions)

	HCA Holdings, Inc. Issuer			HCA Inc. Issuer			Subsidiary Guarantors			Subsidiary Non- Guarantors			Eliminations			Condensed Consolidated
Cash flows from operating activities:
Net income (loss)	$	1,291		$	(1,013	)	$	1,771		$	878		$	(1,348	)	$	1,579
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		30			(131	)		(1,475	)		(1,347	)		—			(2,923	)
Provision for doubtful accounts		—			—			1,505			1,161			—			2,666
Depreciation and amortization		—			—			614			640			—			1,254
Income taxes		250			—			—			—			—			250
Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
Amortization of deferred loan costs		1			43			—			—			—			44
Share-based compensation		39			—			—			—			—			39
Equity in earnings of affiliates		(1,348	)		—			—			—			1,348			—
Other		—			11			—			(4	)		—			7
Net cash provided by (used in) operating activities		263			(1,090	)		2,418			1,321			—			2,912
Cash flows from investing activities:
Purchase of property and equipment		—			—			(685	)		(583	)		—			(1,268	)
Acquisition of hospitals and health care entities		—			—			(72	)		(95	)		—			(167	)
Disposition of hospitals and health care entities		—			—			1			16			—			17
Change in investments		—			—			(9	)		82			—			73
Other		—			—			(1	)		6			—			5
Net cash used in investing activities		—			—			(766	)		(574	)		—			(1,340	)
Cash flows from financing activities:
Issuance of long-term debt		—			1,350			—			—			—			1,350
Net change in revolving bank credit facilities		—			(875	)		—			—			—			(875	)
Repayment of long-term debt		—			(604	)		(16	)		(69	)		—			(689	)
Distributions to noncontrolling interests		—			—			(46	)		(257	)		—			(303	)
Payment of debt issuance costs		—			(20	)		—			—			—			(20	)
Distributions to stockholders		(983	)		—			—			—			—			(983	)
Changes in intercompany balances with affiliates, net		675			1,239			(1,556	)		(358	)		—			—
Income tax benefits		82			—			—			—			—			82
Other		(37	)		—			—			2			—			(35	)
Net cash (used in) provided by financing activities		(263	)		1,090			(1,618	)		(682	)		—			(1,473	)
Change in cash and cash equivalents		—			—			34			65			—			99
Cash and cash equivalents at beginning of period		—			—			115			258			—			373
Cash and cash equivalents at end of period	$	—		$	—		$	149		$	323		$	—		$	472

XML

Investments of Insurance Subsidiaries (Tables)

9 Months Ended

Sep. 30, 2013

Investments Debt And Equity Securities [Abstract]

Schedule of Investments

A summary of our insurance subsidiaries’ investments at September 30, 2013 and December 31, 2012 follows (dollars in millions):

	September 30, 2013
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	383	$	12	$	(2	)	$	393
Auction rate securities		32		—		—			32
Asset-backed securities		13		—		—			13
Money market funds		24		—		—			24
		452		12		(2	)		462
Equity securities		2		1		—			3
	$	454	$	13	$	(2	)		465
Amounts classified as current assets									(63	)
Investment carrying value								$	402

	December 31, 2012
	Amortized Cost		Unrealized Amounts					Fair Value
			Gains		Losses
Debt securities:
States and municipalities	$	395	$	23	$	—		$	418
Auction rate securities		74		—		(6	)		68
Asset-backed securities		14		—		—			14
Money market funds		67		—		—			67
		550		23		(6	)		567
Equity securities		2		1		—			3
	$	552	$	24	$	(6	)		570
Amounts classified as current assets									(55	)
Investment carrying value								$	515

Schedule of Maturities of Investments

Scheduled maturities of investments in debt securities at September 30, 2013 were as follows (dollars in millions):

	Amortized Cost		Fair Value
Due in one year or less	$	41	$	41
Due after one year through five years		176		182
Due after five years through ten years		108		111
Due after ten years		82		83
		407		417
Auction rate securities		32		32
Asset-backed securities		13		13
	$	452	$	462

XML

Assets and Liabilities Measured at Fair Value - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value Disclosures [Abstract]
Estimated fair value of long-term debt	$ 29,492	$ 30,781
Carrying amounts of long-term debt	$ 28,377	$ 28,930

XML

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Nov. 22, 2010	Dec. 06, 2012 Senior Unsecured Notes Due 2021 [Member]	Nov. 23, 2010 Senior Unsecured Notes Due 2021 [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]
Debt instrument, principal amount		$ 1,000	$ 1,525
Debt instrument, stated interest		6.25%	7.75%
Ownership Percentage held by parent	100.00%

XML

Financial Instruments - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Sep. 30, 2013
Offsetting [Abstract]
Estimated amount reclassified from other comprehensive income to interest expense	$ 127
Estimated termination value if there is breach of provision related to derivative agreement	$ 341

XML

Investments of Insurance Subsidiaries - Schedule of Investments (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Available For Sale Securities [Line Items]
Amortized Cost	$ 454	$ 552
Unrealized Amounts, Gains	13	24
Unrealized Amounts, Losses	(2)	(6)
Fair Value	465	570
Amounts classified as current assets	(63)	(55)
Investment carrying value	402	515
Debt Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	452	550
Unrealized Amounts, Gains	12	23
Unrealized Amounts, Losses	(2)	(6)
Fair Value	462	567
Debt Securities [Member] | States and Municipalities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	383	395
Unrealized Amounts, Gains	12	23
Unrealized Amounts, Losses	(2)
Fair Value	393	418
Debt Securities [Member] | Auction Rate Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	32	74
Unrealized Amounts, Gains
Unrealized Amounts, Losses		(6)
Fair Value	32	68
Debt Securities [Member] | Asset-Backed Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	13	14
Unrealized Amounts, Gains
Unrealized Amounts, Losses
Fair Value	13	14
Debt Securities [Member] | Money Market Funds [Member]
Available For Sale Securities [Line Items]
Amortized Cost	24	67
Unrealized Amounts, Gains
Unrealized Amounts, Losses
Fair Value	24	67
Equity Securities [Member]
Available For Sale Securities [Line Items]
Amortized Cost	2	2
Unrealized Amounts, Gains	1	1
Unrealized Amounts, Losses
Fair Value	$ 3	$ 3

XML

Investments of Insurance Subsidiaries - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Schedule of Trading Securities and Other Trading Assets [Line Items]
Investments subject to restrictions	$ 1	$ 9
Available for sale securities expected maturity of debt securities	4 years
Available for sale securities average scheduled maturity	7 years 1 month 6 days
Auction Rate Securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	1 year 4 months 24 days
Available for sale securities average scheduled maturity	22 years 1 month 6 days
Asset-Backed Securities [Member]
Schedule of Trading Securities and Other Trading Assets [Line Items]
Available for sale securities expected maturity of debt securities	3 years 10 months 24 days
Available for sale securities average scheduled maturity	22 years 8 months 12 days

XML

Assets and Liabilities Measured at Fair Value

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value

NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at September 30, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

Derivative Financial Instruments (continued)

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of September 30, 2013 and December 31, 2012, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

	September 30, 2013
				Fair Value Measurements Using
	Fair Value			Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	393		$	—		$	393		$	—
Auction rate securities		32			—			—			32
Asset-backed securities		13			—			13			—
Money market funds		24			24			—			—
		462			24			406			32
Equity securities		3			2			—			1
Investments of insurance subsidiaries		465			26			406			33
Less amounts classified as current assets		(63	)		(24	)		(39	)		—
	$	402		$	2		$	367		$	33
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	4		$	—		$	4		$	—
Interest rate swaps (Income taxes and other liabilities)		323			—			323			—

Derivative Financial Instruments (continued)

	December 31, 2012
	Fair Value			Fair Value Measurements Using
				Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)			Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Investments of insurance subsidiaries:
Debt securities:
States and municipalities	$	418		$	—		$	418	$	—
Auction rate securities		68			—			—		68
Asset-backed securities		14			—			14		—
Money market funds		67			67			—		—
		567			67			432		68
Equity securities		3			1			—		2
Investments of insurance subsidiaries		570			68			432		70
Less amounts classified as current assets		(55	)		(55	)		—		—
	$	515		$	13		$	432	$	70
Liabilities:
Cross currency swap (Income taxes and other liabilities)	$	13		$	—		$	13	$	—
Interest rate swaps (Income taxes and other liabilities)		429			—			429		—

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the nine months ended September 30, 2013 (dollars in millions):

Asset balances at December 31, 2012	$70
Unrealized gains included in other comprehensive income		6
Settlements		(43	)
Asset balances at September 30, 2013	$	33

The estimated fair value of our long-term debt was $29.492 billion and $30.781 billion at September 30, 2013 and December 31, 2012, respectively, compared to carrying amounts aggregating $28.377 billion and $28.930 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

XML

Interim Condensed Consolidated Financial Statements - Additional Information (Detail) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended			9 Months Ended
	Sep. 30, 2013 Hospital	Sep. 30, 2012	Mar. 31, 2011	Sep. 30, 2013 State Surgery_Center Hospital	Sep. 30, 2012	Nov. 22, 2010
Summary Of Significant Accounting Policies [Line Items]
Ownership Percentage held by parent						100.00%
Initial public offering of shares common stock			87,719,300
Number of owned and operated hospitals	162			162
Number of freestanding surgery centers				114
Number of facilities locations				20
General and administrative expense	$ 76	$ 62		$ 207	$ 174
Adjustments to Medicare revenues					188
Adjustment and related expenses added to income before income taxes					170
Adjustment and related expenses added to income before income taxes in diluted per share					$ 0.22
Rural Floor Provision Settlement Effect [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues					271
Implementation of Revised Supplemental Security Income Ratios [Member]
Summary Of Significant Accounting Policies [Line Items]
Adjustments to Medicare revenues					$ 83

XML

Assets and Liabilities Measured at Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $) In Millions, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 465	$ 570
Less amounts classified as current assets	(63)	(55)
Investments of insurance subsidiaries, noncurrent	402	515
Cross Currency Swap (Income Taxes and Other Liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	4	13
Interest Rate Swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	323	429
Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	3	3
Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	462	567
Debt Securities [Member] | States and Municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	393	418
Debt Securities [Member] | Auction Rate Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	32	68
Debt Securities [Member] | Asset-Backed Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	13	14
Debt Securities [Member] | Money Market Funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	24	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	26	68
Less amounts classified as current assets	(24)	(55)
Investments of insurance subsidiaries, noncurrent	2	13
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	2	1
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	24	67
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Money Market Funds [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	24	67
Significant Other Observable Inputs (Level 2) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	406	432
Less amounts classified as current assets	(39)
Investments of insurance subsidiaries, noncurrent	367	432
Significant Other Observable Inputs (Level 2) [Member] | Cross Currency Swap (Income Taxes and Other Liabilities) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	4	13
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Swaps [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Liabilities, Fair Value	323	429
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	406	432
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | States and Municipalities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	393	418
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Asset-Backed Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	13	14
Significant Unobservable Inputs (Level 3) [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	33	70
Investments of insurance subsidiaries, noncurrent	33	70
Significant Unobservable Inputs (Level 3) [Member] | Equity Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	1	2
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	32	68
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Auction Rate Securities [Member]
Fair Value Assets Measured On Recurring Basis [Line Items]
Assets, Fair Value	$ 32	$ 68

XML

Capital Structure

9 Months Ended

Sep. 30, 2013

Text Block [Abstract]

Capital Structure

NOTE 10 — CAPITAL STRUCTURE

The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):

	Equity (Deficit) Attributable to HCA Holdings, Inc.													Equity Attributable to Noncontrolling Interests			Total
	Common Stock				Capital in Excess of Par Value			Accumulated Other Comprehensive Loss			Retained Deficit
	Shares (000)		Par Value
Balances at December 31, 2012		443,200	$	4	$	1,753		$	(457	)	$	(10,960	)	$	1,319		$	(8,341	)
Net income		—		—		—			—			1,132			310			1,442
Other comprehensive income		—		—		—			83			—			—			83
Distributions		—		—		—			—			—			(308	)		(308	)
Share-based benefit plans		4,373		—		71			—			—			—			71
Other		—		—		(3	)		—			1			11			9
Balances at September 30, 2013		447,573	$	4	$	1,821		$	(374	)	$	(9,827	)	$	1,332		$	(7,044	)

The components of accumulated other comprehensive loss are as follows (dollars in millions):

	Unrealized Gains on Available- for-Sale Securities			Foreign Currency Translation Adjustments			Defined Benefit Plans			Change in Fair Value of Derivative Instruments			Total
Balances at December 31, 2012	$	11		$	(1	)	$	(196	)	$	(271	)	$	(457	)
Unrealized losses on available-for-sale securities, net of $3 income tax benefit		(4	)		—			—			—			(4	)
Defined benefit plans, net of $3 of income taxes		—			—			5			—			5
Change in fair value of derivative instruments, net of $3 of income taxes		—			—			—			6			6
Expense reclassified into operations from other comprehensive income, net of $9 and $36, respectively, income tax benefits		—			—			15			61			76
Balances at September 30, 2013	$	7		$	(1	)	$	(176	)	$	(204	)	$	(374	)

XML

Financial Instruments

9 Months Ended

Sep. 30, 2013

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Financial Instruments

NOTE 6 — FINANCIAL INSTRUMENTS

Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at September 30, 2013 (dollars in millions):

	Notional Amount		Maturity Date		Fair Value
Pay-fixed interest rate swaps	$	500		December 2014	$	(6	)
Pay-fixed interest rate swaps		3,000		December 2016		(269	)
Pay-fixed interest rate swaps		1,000		December 2017		(48	)

During the next 12 months, we estimate $127 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. Our cross currency swap is not designated as a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement at September 30, 2013 (amounts in millions):

	Notional Amount		Maturity Date		Fair Value
Euro — United States dollar currency swap		241 Euro		November 2013	$	(4	)

Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the nine months ended September 30, 2013 (dollars in millions):

Derivatives in Cash Flow Hedging Relationships	Amount of Gain Recognized in OCI on Derivatives, Net of  Tax		Location of Loss Reclassified from Accumulated OCI into Operations		Amount of Loss Reclassified from Accumulated OCI into Operations
Interest rate swaps	$	6		Interest expense	$	97

Derivatives — Results of Operations (continued)

Derivatives Not Designated as Hedging Instruments	Location of Gain Recognized in Operations on Derivatives		Amount of Gain Recognized in Operations on Derivatives
Cross currency swap		Other operating expenses	$	9

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of September 30, 2013, we have not been required to post any collateral related to these agreements. If we had breached these provisions at September 30, 2013, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $341 million.

XML

Interim Condensed Consolidated Financial Statements

9 Months Ended

Sep. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Interim Condensed Consolidated Financial Statements

NOTE 1 — INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Reporting Entity

On November 17, 2006, HCA Inc. was acquired by a private investor group, including affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners and HCA founder, Dr. Thomas F. Frist Jr. and by members of management and certain other investors. The transaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. became HCA Holdings, Inc.’s 100% owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. As a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities Exchange Act of 1934.

During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock. Upon the completion of a secondary offering in February 2013, we no longer qualify as a “controlled company” under the applicable New York Stock Exchange (“NYSE”) listing standards and will be required to appoint a board of directors comprised of a majority of independent members within one year of such date. Our common stock is traded on the NYSE (symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At September 30, 2013, these affiliates owned and operated 162 hospitals, 114 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $76 million and $62 million for the quarters ended September 30, 2013 and 2012, respectively, and $207 million and $174 million for the nine months ended September 30, 2013 and 2012, respectively. Operating results for the quarter and the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Basis of Presentation (continued)

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,847			21.8	%	$	1,949			24.2	%
Managed Medicare		794			9.4			720			8.9
Medicaid		401			4.7			378			4.7
Managed Medicaid		386			4.6			380			4.7
Managed care and other insurers		4,636			54.8			4,422			54.8
International (managed care and other insurers)		287			3.4			253			3.1
		8,351			98.7			8,102			100.4
Uninsured		717			8.5			576			7.1
Other		343			4.1			215			2.7
Revenues before provision for doubtful accounts		9,411			111.3			8,893			110.2
Provision for doubtful accounts		(955	)		(11.3	)		(831	)		(10.2	)
Revenues	$	8,456			100.0	%	$	8,062			100.0	%

	Nine Months
	2013			Ratio			2012			Ratio
Medicare	$	5,961			23.5	%	$	6,251			25.4	%
Managed Medicare		2,441			9.6			2,199			8.9
Medicaid		1,098			4.3			1,188			4.8
Managed Medicaid		1,165			4.6			1,080			4.4
Managed care and other insurers		13,777			54.4			13,340			54.3
International (managed care and other insurers)		868			3.4			779			3.2
		25,310			99.8			24,837			101.0
Uninsured		1,809			7.1			1,757			7.1
Other		959			3.8			651			2.7
Revenues before provision for doubtful accounts		28,078			110.7			27,245			110.8
Provision for doubtful accounts		(2,732	)		(10.7	)		(2,666	)		(10.8	)
Revenues	$	25,346			100.0	%	$	24,579			100.0	%

Medicare revenues for the nine months ended September 30, 2012 were impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the nine months ended September 30, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

XML

Segment and Geographic Information - Additional Information (Detail)	0 Months Ended
	Sep. 30, 2013 Hospital
Segment Reporting Information [Line Items]
Number of geographically organized groups	2
Number of owned and operated hospitals	162
Reorganization Group [Member] | National Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	77
Reorganization Group [Member] | American Group [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	79
Reorganization Group [Member] | Corporate and Other [Member]
Segment Reporting Information [Line Items]
Number of owned and operated hospitals	6

XML

Long-Term Debt - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended	9 Months Ended
	Mar. 31, 2013	Sep. 30, 2013
Proforma Debt Instrument [Line Items]
Pretax loss on retirement of debt	$ (17)	$ (17)
Senior Secured Second Lien Notes Due 2017 [Member]
Proforma Debt Instrument [Line Items]
Redemption of aggregate principal amount	$ 201
Debt instrument , Stated interest	9.875%
Percentage of Redemption of principal amount	104.938%

XML

Income Taxes - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Liability for unrecognized tax benefits	$ 417		$ 417		$ 426
Unrecognized tax benefits, accrued interest	26		26		14
Unrecognized tax benefits that would impact effective tax rate	151		151		125
Reductions in interest related to taxing authority examinations	7	1	(8)	(20)
Reductions in interest related to taxing authority examinations net of tax	$ 4	$ 0	$ (5)	$ (13)

XML

Subsequent Event

9 Months Ended

Sep. 30, 2013

Subsequent Events [Abstract]

Subsequent Event

NOTE 13 — SUBSEQUENT EVENT

On November 1, 2013, certain of the Company’s stockholders, consisting principally of affiliates of, or funds sponsored by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co. (the “Selling Stockholders”), sold in an underwritten secondary offering, 30 million shares of its common stock pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission. The Selling Stockholders received all of the proceeds from this offering. Concurrent with the closing of the secondary offering, the Company repurchased approximately $500 million of additional shares (approximately 10,656,400 shares) of its common stock from the Selling Stockholders at the net offering price ($46.92 per share).

XML

Contingencies and Legal Claim Costs

9 Months Ended

Sep. 30, 2013

Commitments And Contingencies Disclosure [Abstract]

Contingencies and Legal Claim Costs

NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.

In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and is currently producing medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action had also been stayed pending developments in the shareholder class actions, but that stay has expired. The plaintiff in the state derivative action subsequently filed an amended complaint on September 9, 2013 that added additional allegations made in the shareholder class actions. The Company has filed a motion to again stay the state derivative action pending developments in the class action, but the Court has not yet acted on that motion. On September 24, 2013, an additional state derivative action, Steinberg v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court. This action against our board of directors is substantially similar to the earlier filed state derivative action and the Company is attempting to consolidate the two state actions.

Health Midwest Litigation

In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. Should the accounting fail to satisfy the Court concerning HCA’s compliance with its capital and charity care commitments, the amount of the judgment award could substantially increase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are about $12 million. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling. The accounting for HCA’s capital expenditures and charity and uncompensated care is ongoing and will likely not be concluded before the end of 2013. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters final judgment.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2013

Earnings Per Share [Abstract]

Schedule of Computations of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share for the quarters and nine months ended September 30, 2013 and 2012 (dollars in millions, except per share amounts, and shares in thousands):

	Quarter				Nine Months
	2013		2012		2013		2012
Net income attributable to HCA Holdings, Inc.	$	365	$	360	$	1,132	$	1,291
Weighted average common shares outstanding		447,329		440,899		446,125		439,441
Effect of dilutive incremental shares		16,240		18,616		16,926		19,381
Shares used for diluted earnings per share		463,569		459,515		463,051		458,822
Earnings per share:
Basic earnings per share	$	0.82	$	0.82	$	2.54	$	2.94
Diluted earnings per share	$	0.79	$	0.78	$	2.44	$	2.81

XML

Interim Condensed Consolidated Financial Statements (Policies)

9 Months Ended

Sep. 30, 2013

Fair Value Disclosures [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.

The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $76 million and $62 million for the quarters ended September 30, 2013 and 2012, respectively, and $207 million and $174 million for the nine months ended September 30, 2013 and 2012, respectively. Operating results for the quarter and the nine months ended September 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

Basis of Presentation (continued)

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,847			21.8	%	$	1,949			24.2	%
Managed Medicare		794			9.4			720			8.9
Medicaid		401			4.7			378			4.7
Managed Medicaid		386			4.6			380			4.7
Managed care and other insurers		4,636			54.8			4,422			54.8
International (managed care and other insurers)		287			3.4			253			3.1
		8,351			98.7			8,102			100.4
Uninsured		717			8.5			576			7.1
Other		343			4.1			215			2.7
Revenues before provision for doubtful accounts		9,411			111.3			8,893			110.2
Provision for doubtful accounts		(955	)		(11.3	)		(831	)		(10.2	)
Revenues	$	8,456			100.0	%	$	8,062			100.0	%

	Nine Months
	2013			Ratio			2012			Ratio
Medicare	$	5,961			23.5	%	$	6,251			25.4	%
Managed Medicare		2,441			9.6			2,199			8.9
Medicaid		1,098			4.3			1,188			4.8
Managed Medicaid		1,165			4.6			1,080			4.4
Managed care and other insurers		13,777			54.4			13,340			54.3
International (managed care and other insurers)		868			3.4			779			3.2
		25,310			99.8			24,837			101.0
Uninsured		1,809			7.1			1,757			7.1
Other		959			3.8			651			2.7
Revenues before provision for doubtful accounts		28,078			110.7			27,245			110.8
Provision for doubtful accounts		(2,732	)		(10.7	)		(2,666	)		(10.8	)
Revenues	$	25,346			100.0	%	$	24,579			100.0	%

Medicare revenues for the nine months ended September 30, 2012 were impacted by two adjustments to Medicare revenues (the Rural Floor Provision Settlement which increased revenues by approximately $271 million and the implementation of revised Supplemental Security Income ratios which reduced revenues by approximately $83 million). The net effect of these Medicare adjustments was an increase of $188 million to revenues. The net effect of these adjustments (and related expenses) added $170 million to income before income taxes, or $0.22 per diluted share, for the nine months ended September 30, 2012.

Certain prior year amounts have been reclassified to conform to the current year presentation.

Fair Value Measurements and Disclosures

Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) defines fair value, establishes a framework for measuring fair value and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at September 30, 2013 and December 31, 2012, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

XML

Document and Entity Information	9 Months Ended
	Sep. 30, 2013	Oct. 31, 2013
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q3
Entity Registrant Name	HCA HOLDINGS, INC.
Entity Central Index Key	0000860730
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		447,838,000

XML

Interim Condensed Consolidated Financial Statements (Tables)

9 Months Ended

Sep. 30, 2013

Quarterly Financial Information Disclosure [Abstract]

Schedule of Revenues from Third Party Payers and Uninsured

revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and nine months ended September 30, 2013 and 2012 are summarized in the following table (dollars in millions):

	Quarter
	2013			Ratio			2012			Ratio
Medicare	$	1,847			21.8	%	$	1,949			24.2	%
Managed Medicare		794			9.4			720			8.9
Medicaid		401			4.7			378			4.7
Managed Medicaid		386			4.6			380			4.7
Managed care and other insurers		4,636			54.8			4,422			54.8
International (managed care and other insurers)		287			3.4			253			3.1
		8,351			98.7			8,102			100.4
Uninsured		717			8.5			576			7.1
Other		343			4.1			215			2.7
Revenues before provision for doubtful accounts		9,411			111.3			8,893			110.2
Provision for doubtful accounts		(955	)		(11.3	)		(831	)		(10.2	)
Revenues	$	8,456			100.0	%	$	8,062			100.0	%

	Nine Months
	2013			Ratio			2012			Ratio
Medicare	$	5,961			23.5	%	$	6,251			25.4	%
Managed Medicare		2,441			9.6			2,199			8.9
Medicaid		1,098			4.3			1,188			4.8
Managed Medicaid		1,165			4.6			1,080			4.4
Managed care and other insurers		13,777			54.4			13,340			54.3
International (managed care and other insurers)		868			3.4			779			3.2
		25,310			99.8			24,837			101.0
Uninsured		1,809			7.1			1,757			7.1
Other		959			3.8			651			2.7
Revenues before provision for doubtful accounts		28,078			110.7			27,245			110.8
Provision for doubtful accounts		(2,732	)		(10.7	)		(2,666	)		(10.8	)
Revenues	$	25,346			100.0	%	$	24,579			100.0	%